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It is estimated that as many as 50% of people suffering from Whiplash -Associated Disorders 
(WAD) may experience chronic alterations of their activities of daily living as much as 1-
year post injury. Despite their burden, there is little to evidence to suggest why some people 
may be more likely to acquire WAD or develop chronic symptomology. Additionally, the 
link between biomechanical forces at the time of impact and symptom development or 
recovery is poor. As a result, interest in alternative theories such as stress system reactivity 
have received interest in recent literature, but empirical methods to test them has been 
lacking. Thus, the purpose of this thesis was to explore the relationship between stress and 
trauma using a known stressor and a newly developed virtual reality (VR)-based car crash 
simulator to better understand the immediate reaction to being involved in a motor vehicle 
crash (MVC). In Chapter 2, we evaluated conditioned pain modulation (CPM) in reaction to 
the cold pressor task and measured associations with indices of sympathetic and 
hypothalamic-pituitary-adrenal function. It was found that only 30% of participants 
experienced inhibitory CPM. Within this group, there was a positive moderate correlation 
between CPM and the absolute change in skin conductance pre-to-post cold pressor task. In 
Chapter 3, we explored the initial tolerability to a novel VR-based car crash simulator in 
healthy subjects and also evaluated sense of presence and simulator sickness. The system was 
well tolerated by a majority of participants, and it appeared that the sense of presence and 
simulator sickness shared an inverse relationship. In Chapter 4, we evaluated the pain and 
stress response to our VR-based car crash simulator in the form of pain pressure detection 
thresholds, CPM, heart rate variability, and salivary cortisol. Over 40% of participants were 
more sensitive to pain following the simulation, and this may have been associated with an 
increase in parasympathetic nervous system activity and salivary cortisol. These results may 
help to explain some of the heterogeneity of WAD presentations after a MVC and signify 
that the pain/stress response to simulated trauma is variable. 
Keywords 
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Summary for Lay Audience 
While there has been much research over the last 20 years to understand car crashes, it 
remains unclear why some people develop neck pain and others do not. This collection of 
symptoms immediately after a car crash is referred to as Whiplash. Recent research has 
suggested that neck pain after a car crash could be due to high amounts of stress that are felt 
during a car crash. Unfortunately, until now there has been no way to test this theory. We 
recently created a new virtual reality based simulator that is designed to mimic the 
experience of being in a car crash without the physical injury. Thus, this research project was 
designed to examine how healthy people react to being involved in a virtual reality car crash.  
The first project in this thesis was designed to look at how healthy people react to being 
stressed using a common way of generating stress. We did this by placing healthy people’s 
hands into cold water and measuring their nervous system activity and their pain before and 
after. It appeared that some people become less sensitive to pain and that this was associated 
with the ‘fight’ aspect of the fight or flight response. For the second project in this thesis, we 
wanted to see if healthy people could tolerate exposure to a virtual reality car crash. We also 
measured how much they felt like they ‘were actually there’ and if they became sick or not. 
Most people were able to tolerate this virtual reality car crash and that as the feeling of ‘being 
there’ increased, sickness decreased. The third project in this thesis looked how healthy 
people responded to a virtual reality car crash in terms of their pain and nervous system 
activity. We surprisingly found that some people become more sensitive to pain after a 
virtual car crash and that this was associated with the ‘flight’ aspect of the fight or flight 
response. With this information, we may be able to start better understanding why some 
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Chapter 1  
1 Introduction 
1.1 The Burden of Neck Pain 
The experience of pain is one of the most complex, universal, and fundamental human 
experiences, which is also the most common reason why patients seek medical care.1 It is 
generally accepted that the individual experience of pain is the result of some 
combination of biological, psychological and sociocultural factors.2 Due to its multiple 
inputs, The International Association for the Study of Pain re-defined pain as, “An 
unpleasant sensory and emotional experience associated with, or resembling that 
associated with, actual or potential tissue damage.”3 Chronic pain is estimated to affect 
18.9% of adults in Canada, with half having lived with chronic pain for over 10 years.4 
Specifically, neck pain (NP) (as of 2019) constituted the 12th leading cause of years lived 
with disability globally, while road injuries were the 7th leading cause of disability-
adjusted life years.5  
Recent concept mapping has suggested that the impact of NP extends far beyond the 
physical, with influences on performing activities of daily living, social participation and 
financial consequences.6 People suffering from NP have also expressed that they have 
faced misunderstanding regarding their condition from their families and employers.6 
Unfortunately, despite its burden, the cause of NP is not always evident and thus makes 
treatment options for its sufferers challenging.7,8 NP can arise from any structure in the 
neck including but not limited to muscles, ligaments, joints, and intervertebral discs.9 As 
a result, most NP has been labelled as non-specific NP to reflect this problem and can 
generally be broadly sub-divided into two categories: traumatic and non-traumatic.10 One 




1.2 Motor Vehicle Crashes and Whiplash-Associated 
Disorders 
Exposure to either a rear-end or side-impact MVC can impart an acceleration-
deceleration transfer of energy to the head and neck, which is known as a Whiplash 
mechanism of injury.12 The term MVC is used instead of motor vehicle accident (MVA) 
to reflect that calling these events accidents undermines the experience of their 
sufferers.13 In turn, Whiplash-Associated Disorders (WAD) refer to the range of 
symptoms that result after a MVC from an acceleration-deceleration mechanism of 
injury.14 The symptoms of WAD can include but are not limited to: neck pain, loss of 
range of motion of the neck, neurological signs and even fracture of the cervical spine.15  
Due to the myriad of presentations, the Quebec Task Force classified patients with 
whiplash16 as:  
- Grade 0: No injury. No neck complaints. No physical signs 
- Grade 1: Injuries for which there is a complaint of neck pain, or stiffness, or 
tenderness. No physical signs 
- Grade 2: Injuries for which there is a neck complaint and physical sign such as 
loss of range of motion or point tenderness 
- Grade 3: Injuries for which there is a neck complaint and neurological signs such 
as decreased sensation and/or weakness 
- Grade 4: Injuries for which there is a neck complaint and cervical fracture 
Interest in prognosis from whiplash injuries has seen great interest as half of affected 
adults have resolution of their symptoms (without intervention) while the remainder will 
experience either prolonged recovery or chronic symptomology.11,17 Prior work has also 
shown that, amongst other factors, the experience of higher pain severity shortly after 
injury is a strong predictor of poor outcomes 6 to 12 months later.18 Despite numerous 
studies elucidating various prognostic factors in the recovery of WAD, recovery rates 




1.3 Historical Models of WAD 
Historical models of WAD have been explored from the basis of a pathoanatomical 
model of injury.19 Cadaveric biomechanical studies demonstrated that in a rear-end 
MVC, the cervical spine experiences a reversed S- shaped curve leading to lower cervical 
spine hyperextension and upper cervical spine flexion.21,22 Thus, it was postulated that 
this mechanism could result in increased shearing and tensile forces at individual cervical 
levels leading to injury of the soft tissues of the neck.21,22  Most notably, the facet joints 
of the cervical spine have been implicated in NP due to their potential for nociception and 
their capsular strain during a whiplash event.22–24 Cervical radiofrequency neurotomy of 
facet joints in patients with chronic WAD has been shown to improve pain and disability 
scores even 3 months following the procedure.24 However, even in patients who received 
radiofrequency neurotomy of their facet joints, they still present with mild to moderate 
pain.24  
In spite of biomechanical studies, traditional diagnostic imaging (e.g., plain films or 
magnetic resonance imaging) have been unable to consistently and accurately detect the 
presence of soft tissue lesions in patients with WAD.25 Nevertheless, it has been 
suggested that 40 to 45% of patients with chronic WAD likely have a peripheral articular 
lesion responsible for their NP.19 There also appears to be little association between crash 
parameters such as speed and direction of collision, or awareness of impending collision 
and recovery from development of WAD.17,19,26 Further complicating WAD, is that there 
is little evidence to suggest why one individual may experience a lack of symptoms from 
a high force collision, while someone else may present with significant symptomology 
from a low-speed perturbation.20 Due to the disparity between these findings, newer 
models for understanding WAD have been proposed. 
1.4 New lntegrated Models of WAD 
To try and reconcile gaps in the literature and to help explain the heterogeneity of the 
clinical presentation of WAD, Walton and Elliot (2017) proposed an Integrated Model of 
WAD, drawing upon previous work in both the Fear-Avoidance Model of Pain as well as 
the Diathesis-Stress model of pain.19 The Fear-Avoidance model of pain postulates that 
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when pain is experienced, there are two likely outcomes.27 The first is one of recovery 
where the situation is seen as non-threatening, thereby the person is likely to stay 
engaged in functional activities that promote recovery. The second outcome is one of 
prolonged suffering, in which fear of pain leads to fear of movement which leads to a 
vicious cycle where pain can be catastrophized leading to the potential for further pain 
and suffering. The Diathesis-Stress model of pain on the other hand sought to give 
considerations to the interactions of individual predisposing factors in the reaction to 
trauma.2  
Diatheses can be individual personal and contextual variables (e.g., psychological, 
genetic) that either lead to protection or vulnerability in the context of injury.19 Walton 
and Elliot (2017) built upon these theories to present an integrated model of WAD that 
fully considers the interaction effects between psychological and neurobiological systems 
as well as their contributions from personal and environmental factors.19 Also included in 
this model was the idea that the MVC acted as a unique catalyst that led to a cascade of 
both physiological and psychological responses to protect from injury.19 These responses 
are thought to include an acute stress response to trauma, that has been postulated to be 
abnormal or maladaptive in those who develop chronic WAD.19,28 
1.5 Stress Reactivity and Pain 
A stressor can be defined as circumstances that threaten the physical and/or psychological 
state of the individual.29,30 In response, the individual may experience distress which 
consists of a psychological appraisal of the situation and can include both the feelings of 
anxiety and/or feeling overwhelmed.30 While the term distress expresses a negative 
connation, some degree of distress is considered advantageous in reaction to a stressor, as 
individuals who experience little distress may also be at risk of developing 
psychopathology.19,31Distress is a separate experience from that of eustress which has 
been typically been defined as ‘good stress’ and includes an optimal stress response to a 
stressor to a stressor that the individual has appraised as non-threatening (e.g., exercise).32 
The psychological appraisal of the situation at hand is assessed by the prefrontal cortex, 
hypothalamus, and amygdala which determine if the circumstance is threatening to the 
homeostasis of the body.33  
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Next, the body experiences two major physiological processes: the fast activation of the 
sympathetic nervous system (SNS) component of the autonomic nervous system (also 
known as the sympathetic-adreno-medullary (SAM) axis), and the slow activation of the 
hypothalamus-pituitary-adrenal (HPA) axis.33–35 Activation of the SNS leads to an 
increase in heart rate, blood pressure, and perspiration, while activation of the HPA axis 
ultimately leads to the release of the stress hormone cortisol.33,34 Cortisol aids the body in 
its ability to use glucose for fuel and is also a potent anti-inflammatory.36 However, under 
chronic stress conditions, elevated cortisol levels can lead to its dysfunction causing 
increased systemic inflammation and pain.36 Acute activation of these systems (SNS & 
HPA axis) can lead to stress-induced analgesia (SIA) to help protect the individual from 
harm, which is controlled by descending opioid and non-opioid brain circuits.37,38  
If the stressor includes a noxious or painful stimulus, then activation of a similar yet 
unique system known as Diffuse Noxious Inhibitory Control (DNIC) can also occur 
simultaneously.38 DNIC consists of a spinal-medullary-spinal pathway that can be 
activated for pain inhibition in response to a painful stimulus, more commonly referred to 
as ‘pain inhibits pain’.39 Interest in DNIC and stress reactivity in chronic WAD patients 
has been gaining interest in recent years, as both impaired DNIC40 and stress 
reactivity28,41 have been implicated in patients suffering from chronic WAD. Due to these 
findings, there has been a push to try and identify both physical and psychological factors 
that may be predictive in determining outcomes after whiplash injuries for the 
development of chronic pain.42 
1.6 Pain and Stress Measurement as Biomarkers for 
Chronic Pain 
Conditioned Pain Modulation (CPM) is one technique that has seen increasing use and is 
conceptualized as a means to evaluate the functioning of pain inhibitory pathways (i.e., 
DNIC).43 CPM protocols typically consist of exposing participants to a testing stimulus 
before and after exposing them to a different noxious conditioning stimulus. The testing 
stimulus is commonly a measure of pain pressure detection threshold (PPDT)(e.g., 
mechanical or thermal) and the difference in threshold between the pre- and post-
exposure to the conditioning stimulus is considered the CPM.43,44 Assuming well-
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functioning DNIC, pain thresholds normally increase (the system becomes less sensitive 
to the testing stimulus) following exposure to the conditioning stimulus, though negative 
CPM, considered dysfunctional DNIC, is a consistent feature of chronic pain 
presentations (e.g., fibromyalgia).45 However, recent evidence has suggested that CPM 
may not be a universal finding, even among healthy individuals.44,46 
Stress reactivity is also of interest in the context of WAD, as chronic WAD shares 
common psychological sequelae with those suffering from post-traumatic stress disorder 
(PTSD).19,47 Stress reactivity can be captured using non-invasive measurement tools such 
as Galvanic Skin Response and Heart Rate Variability (HRV).48,49 Galvanic Skin 
Response (GSR) has been shown to be one of the quickest non-invasive evaluative tools 
through which to evaluate a physiological stress.50,51 GSR is a measure of a change in the 
electrical properties of the skin, where more sweat (moisture) reduces current resistance 
in reaction to a noxious stimulus due to activation of the SNS.52 This happens on a 
millisecond scale and is completely outside of voluntary control, making it an attractive 
metric for stress research.50,53 HRV is a physiological measure that has been used as a 
clinical proxy of autonomic tone (sympathetic: parasympathetic balance) in healthy and 
diseased states.54,55 While there are many methods to measure HRV using standard ECG 
recordings, the time domain methods (e.g., root mean square of the successive differences 
(RMSSD) between normal heartbeats), are some of the simplest to perform, appear to be 
clinometrically robust, and can be captured in a 5 minute period.55 HRV in particular has 
been shown to be decreased in subjects with chronic WAD in comparison to healthy 
controls.56 
1.7 Opportunities for Innovative Technologies in 
Understanding WAD 
Unfortunately, many of these newly proposed theories and/or models of WAD have 
remained firmly fixed in the theoretical phase as it isn’t feasible or ethical to place 
subjects in live car crashes for scientific research.57 Emerging technologies in the form of 
driving simulators could be a novel method through which the experience of a MVC can 
be replicated without the potential for tissue damage or excessive biomechanical forces.57 
To date, lab-based research involving driving simulators has been limited to exposure 
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therapy studies for treatments of patients suffering from PTSD or intervention to alter 
driving behaviour.58,59 One promising technology in this domain is the use of virtual 
reality (VR). VR can be understood as technologies that produce a virtual environment 
via hardware or software that simulates real-world objects or events and allows the 
subject to interact with the virtual environment.60,61 VR relies on interactivity and 
immersion to create a sense of presence, and interactivity to either replicate real world 
environments or imaginative settings.62 Immersion in this context refers to the objective 
level of sensory feedback and/or fidelity that a of which a VR system is capable.63 
In an interesting study simulating a MVC before the advent of VR, Castro and colleagues 
(2001) exposed healthy participants to what they termed a placebo car crash. This 
experimental setup was designed such that participants would experience sudden braking, 
and glass shattering to believe that they had been involved in a rear-end MVC without 
actual vehicle collision.64 This study reported that up to 20% of participants can 
experience symptoms of WAD, even in reaction to a placebo car crash.64 It could be 
argued however that this experimental setup was not as immersive as that of a VR-format 
in which the subject can be fully immersed in the experience. As such, exposure to a VR-
based MVC may be able to allow subjects believe that they are participating in a MVC, 
such that the effects of low-speed MVC with low biomechanical forces can be directly 
observed. Additionally, the work of Castro and colleagues (2001) also relied on symptom 
self-report, and therefore it is unclear if there were any objective physiological findings 
present in those that experienced WAD-like symptoms.64 Again, a VR-based MVC could 
be advantageous in simulating various MVC crash types (e.g., rear-end vs side-impact) 
with real-time physiological monitoring from both pain and stress measurement 
perspectives. 
1.8 Overall Purpose 
The overall purpose of this thesis was to explore CPM and measures of stress system 
reactivity in reaction to both a known stressor (e.g., cold pressor task) and a novel VR-
based road collision simulator. We understood that this line of work would likely raise 
more questions than it would answer but were hopeful that it might help to illuminate 
why symptoms of WAD may persist in the absence of biomechanical forces that impart 
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tissue damage. It was also our hope that this work would fundamentally aid patients in 
understanding why they have their symptoms while others do not. Thus, the work of this 
thesis is presented in three separate but related main chapters.  
The aim of Chapter 2 of this thesis was to identify meaningful CPM in a cohort of 
healthy young adults in reaction to the cold pressor task and to explore relationships with 
measurements of stress system reactivity (e.g., skin conductance and salivary cortisol). 
We envisioned this study as a comparator with other studies examining pain responses to 
different conditioning stimuli. This study was also designed to contribute to the growing 
body of literature in identifying meaningful CPM.  
The aim of Chapter 3 was to explore the initial tolerability of participants using a novel 
virtual reality-based road collision simulator designed to mimic the experience of being 
the passenger in a car crash. This study was also designed to gather user feedback 
regarding sense of presence and simulator sickness to help refine the simulator for future 
use. Adverse events were also recorded to help refine the simulator for future study. 
The aim of Chapter 4 of this thesis was to begin to examine the range of physiological 
reactions to a novel virtual reality-based road collision simulator. We explored CPM 
using the VR-based MVC as a conditioning stimulus with PPDT as our testing stimulus, 
again examining for meaningful CPM based on literature recommendations. We also 
explored any relationships with measurements of autonomic nervous system reactivity 
such as heart rate variability.  
We envisioned this work as the start of a new research initiative designed to explore the 
experience of involvement in a MVC without the potential for tissue injury. By viewing a 
car crash as a catalyst towards the development of neck pain, we are hopeful that future 
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Chapter 2  
2 Exploring the Relationship between Conditioned Pain 
Modulation Efficacy and Stress System Reactivity in 
Healthy Adults in Reaction to the Cold Pressor Task 
2.1 Introduction 
Conditioned Pain Modulation (CPM) is a technique used to evaluate the functioning of 
pain inhibitory pathways in the human body.1 CPM protocols consist of exposing 
participants to a testing stimulus before and after exposure to a noxious conditioning 
stimulus, which historically has been the Cold Pressor Task (CPT), though a variety of 
conditioning stimuli can be used. 1–3  Previous literature has demonstrated that the use of 
cold water immersion can be used for sessions up to three minutes in duration before self-
reported pain becomes too intense.4 The testing stimulus is commonly pain detection 
threshold and the difference in the testing stimulus threshold between the pre- and post-
exposure is considered the metric for CPM.1 Prior recommendations have suggested that 
CPM is best conceptualized as the absolute change or percentage change in the testing 
stimulus from pre-to-post exposure in order to compare results across studies and 
institutions.4  In healthy adults, it is thought that CPM is typically positive (i.e., an 
increase in pain threshold) in nature, though prior work has found that negative/impaired 
CPM is a common feature of chronic pain syndromes.5   
Complicating this matter is that some prior studies have identified non-responders in 
CPM research, with a paucity of evidence exploring the proportion of healthy participants 
without pain that also show reversed CPM under normal clinical conditions.4 As such, 
there have been attempts to define what constitutes true meaningful change in CPM 
measurements, beyond simple measurement error. Previously, Kennedy and colleagues 
(2020) used a distribution-based statistical approach based on two standard errors of 
measurement (SEM) of the testing stimulus to classify participants as having experienced 
inhibition (i.e., increase in pain threshold), facilitation (i.e., decrease in pain threshold), 
and non-response (i.e., no appreciable change).6 Despite this classification system, it is 
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unclear what individual factors may contribute to the experience of these responses, 
though higher state anxiety was associated with inhibitory CPM effect.6 
Geva and Defrin (2018) also recently found a relationship between CPM and perceived 
stress in that those participants who experienced a perceived high stress response had 
reduced CPM.7 However, these authors were unable to demonstrate a relationship 
between CPM and physiological measures of the stress response such as salivary cortisol 
or Galvanic Skin Response (GSR), nor did they explore meaningful CPM as it relates to 
these measurements. Salivary cortisol and GSR are promising measures of stress system 
reactivity as they provide estimates of sympathetic nervous system (SNS) and the 
hypothalamic-pituitary-adrenal (HPA) axis.8  
In recent years, CPM has been highlighted as a potential biomarker for the development 
of chronic pain, although questions remain regarding its validity as a biomarker 
considering it is fully dependent on participant perception of and willingness to report  
pain.4,9 Concurrently, a maladaptive or exaggerated stress response has been reported as a 
potentially important mechanism through which chronic pain following trauma is 
developed.10,11 Inversely, it has also been suggested that people who experience a lack of 
a stress response or a blunted one, may also be at risk of developing pain and/or 
psychopathology following trauma.12,13 As such, it appears that there may be a 
relationship between stress (exaggerated or blunted) and pain; however, the directionality 
of this relationship requires further investigation.14 Thus, the purpose of this study was to 
explore the relationship between statistically meaningful CPM after exposure to a CPT 




This was a cross-sectional study with repeated measures design. Participants had their 
pain pressure detection threshold (PPDT), GSR, and cortisol measured before and after 




A convenience sample of participants was recruited from Western University between 
February 2019 and March 2020. Eligible participants were 18 years or older, without 
recent musculoskeletal injury for two weeks, and could read/write conversational 
English. Exclusion criteria were: infection, cardiovascular instability, cancer, Raynaud’s 
phenomenon, cryoglobulinemia, stroke, multiple sclerosis, amyotrophic lateral sclerosis, 
and cervical radiculopathy. Participants were required to discriminate between thermal 
stimuli using hot/cold test tubes and light touch using a 200mg Von Frey filament on the 
neck as part of the screening protocol for eligibility. Recruitment was purposive to ensure 
equal representation of sexes given the clear sex bias in biomedical research.15 This study 
was approved by the Health Sciences Research Ethics Review Board at Western 
University (London, ON, Canada) prior to commencement and all participants provided 
written informed consent and the rights of the subjects were protected. 
Experimental Protocol 
All participants were asked to refrain from consumption of food/ drink, analgesic 
medications, and any physical activity for the hour before testing. On the first testing day, 
participants completed a study-specific demographic questionnaire indicating their age 
and sex. Participants then sat in an isolated room for five minutes with consistent 
lighting, noise, and temperature.  
PPDT 
PPDT was evaluated using the protocol of Walton et al. (2011).16 This protocol consists 
of testing PPDT at upper fibers of the trapezius muscle using a handheld digital 
algometer (Wagner FDX-25, Wagner Instruments, Greenwich CT, USA) on the 
participant’s dominant side. Increasing force was applied to the angle of the upper 
trapezius and participants were instructed to verbalize ‘there’ when the sensation changed 
from pressure to pain. The rate of application was 5N/second and the rater was trained 
until they could perform this rate of application consistently. The value of the algometer 
at verbalization was recorded in kilograms of force (kgf). The process was repeated three 
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times with 30 seconds between testing, and the average of these three sessions was the 
baseline PPDT.  
GSR 
In order to evaluate peripheral sympathetic nervous system activity, participants had their 
GSR measured using ADInstruments PowerLab (PowerLab®, ADInstruments, Sydney, 
Australia) at a sampling rate of 1000 Hz using two finger cuffs on the participants non-
dominant hand on the second and fourth fingers. GSR was measured in microsiemens 
(uS) zeroed to each participant prior to use to determine a relative change in skin 
conductance from their baseline resting state. Measurements relative to each subject’s 
resting state were used to avoid any baseline variability in GSR which may have been 
influenced by circadian systems, to isolate the stress response to the stressor used in the 
present study.17,18 GSR was recorded over a five-minute baseline period, during the 
experimental pain protocol, and two 5-minute periods during recovery (0 to 5 minutes, 5 
to 10 minutes). Participants were also asked to minimize any movements of their non-
dominant hand and fingers to minimize measurement errors.  
Salivary Cortisol 
With the GSR sensors still in place, a salivary sample was collected from each participant 
prior to the CPT using a small poly-cotton swab. Each participant rolled the swab around 
the inside of their mouth for about 30 seconds before returning it to a sterile salivette. The 
salivette was then sealed, and immediately transferred to a -30C freezer for later off site 
analysis. Salivary cortisol (Cortisol (Saliva) ELISA, Alpco (Salem, NH, USA), cat no.11-
CORHU-E01-SLV) was analyzed using typical industry standard approaches based on 
the specifications set by the manufacturer and all samples were run in duplicate, whereby 
the values were the average of the two duplicate samples. 
 
Cold Pressor Task 
Experimental pain was simulated with the CPT. Similar to the protocol of Kaunisto et al. 
(2013),19 participants submerged their dominant hand up to the wrist into an ice-water 
bath (2-4 degrees centigrade) in a cooler with dimensions 16.5 cm x 12.4 cm x 13 cm. 
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The ice was separated from the participants hand with a mesh basket and temperature was 
monitored using a submersible digital thermometer. The water was mechanically agitated 
regularly and temperature was checked in several spots to ensure a consistent 
temperature. No pump was used as preliminary testing found interference with the GSR 
readings. Participants kept their hand submerged until they experienced an 8/10 on the 
Numeric Pain Rating Scale (NPRS)  (0 = no pain to 10 = extreme pain) or until 90 
seconds had elapsed, whichever came first. Kennedy et al. (2016) recently highlighted 
that a conditioning stimulus must not be overly painful, otherwise it may not be tolerated 
by all participants.4 As such, an 8/10 on the NPRS was selected as a cut-off as it was 
deemed sufficiently noxious, but not overly painful such that the CPT could be tolerated 
by a majority of participants. Participants rated their pain  every 10 seconds. Cold 
endurance time was recorded to the nearest 0.1 seconds using a digital stopwatch. 
Following the CPT, participants dried their hands and sat quietly for 30 seconds after 
which PPDT and salivary cortisol were re-evaluated. PPDT was re-measured by the same 
rater that performed the baseline test in a sequential manner. GSR measurement 
continued throughout both the CPT and during recovery for offline analysis.   
 
Statistical Analysis 
Descriptive statistics (mean, standard deviation) were calculated for participant 
demographics, PPDT, CPM, GSR, and salivary cortisol at baseline and after the CPT. For 
descriptive purposes, participants’ cold endurance time was coded as either 1 (immersion 
= 90 seconds) or 2 (immersion < 90 seconds) and was reported as the frequency of 
participants to reach the full immersion time. The other metrics (PPDT, GSR, and 
salivary cortisol) were retained as ratio-level variables (microsiemens or ng/ml).  Data 
were visualized via box-and-whisker plots and outliers were identified through visual and 
statistical tests of normality (Kolmogorov-Smirnov tests). PPDT values were 
logarithmically transformed for parametric statistics, as they were not normally 




A one way repeated measures analysis of variance (rmANOVA)was used to detect any 
significant changes in mean 5-minute GSR intervals at each testing point compared to 
baseline testing, with a Bonferroni correction factor applied (T1 = 5 minute baseline, T2 
= during CPT, T3 = 0 to 5 minutes after CPT, and T4 = 5 to 10 minutes after CPT). 
While GSR can be measured with parameters like amplitude or recovery time,20 only 
average skin conductance was used due to the prolonged exposure of the CPT, which was 
not an acute startle event. A paired samples t-test was used to compare mean difference in 
cortisol and PPDT before and after the CPT. The difference between PPDT before and 
after the CPT was the CPM and was analyzed as both absolute change (CPMABS = Post - 
Pre immersion (in kgf)) and percent change (CPMPERCENT = ∆CPMABS/Pre immersion kgf 
x100) as per the recommendations of Kennedy et al. (2016).4 
Meaningful CPM  
Next, the recommendations of Kennedy et al. (2020) were used to explore meaningful 
CPM.6 The reliability of the baseline PPDT was evaluated using an intraclass correlation 
coefficient (ICC3,1). ICCs were interpreted as suggested by Shrout & Fleiss
21 where 
values less 0.4 were poor, between 0.4 and 0.59 was fair, between 0.60 and 0.75 was 
good, and greater than 0.75 was excellent. From this, the standard error measurement was 
calculated for the baseline PPDT ((SEM = pooled standard deviation of baseline PPDT 
(SDpooled)√(1-ICC)). Per the protocol of Kennedy et al. (2020) + 2 SEM were used to 
group participants into three classification groups (inhibition = increase in 
threshold/decreased sensitivity, facilitation = decrease in threshold/increased sensitivity, 
and non-response).6 Both the absolute and percentage change of + 2 SEM were used to 
account for those participants who may have had a minor increase in absolute PPDT, but 
a large percentage change relative to their baseline measurement. Descriptive values of 
both the pain and stress metrics were also calculated for participants within these groups.  
Associations between CPM Classification and Indicators of Stress 
Pearson correlations were used to explore any initial relationships between CPM 
classification and the changes in salivary cortisol and GSR before and after the CPT as a 
measure of stress system reactivity. Strength of Pearson correlations were interpreted 
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using the recommendations of Mukaka (2012), whereby: <0.30 (negligible), 0.30 to 0.50 
(low), 0.50 to 0.70 (moderate), 0.70 to 0.90 (high), >0.90 (very high).22 Scatter plots were 
used to visually model the date for interpretation.  
All statistical analyses were completed using IBM SPSS Statistics Version 27 and the p-
value for statistical significance was set at 0.05. 
 
Sample Size Calculation 
For this study, no formal sample size was calculated due to the exploratory nature of the 
work, though a similar number of participants (n=50) were sought compared to other 
studies investigating meaningful CPM in healthy adults.6  
2.3 Results 
Descriptive Statistics 
50 healthy participants (male = 25, female =25) were included in the study with a mean 
age of 24.5 + 3.3 years (18 to 35)(Table 1). No subjects reported their sex as different 
from their self-reported gender; thus, only sex is reported. 52% (26/50) of participants 
tolerated the full 90 seconds of the CPT used in the present study. Mean PPDT values 
across the full sample were not significantly different from baseline to after the CPT; see 
Table 2 for a full description of values. The one-way repeated measures ANOVA 
revealed that there was a statistically significant main effect for testing time for mean 5-
minute GSR (F=44.58, p=0.001), with post hoc pairwise comparisons indicating GSR 
was significantly elevated from baseline (6.08 + 8.77 uS, 95%CI: 3.45 to 8.72 uS) at all 
subsequent time points (all p<0.001) during the CPT (15.25 + 9.30 uS , 95%CI: 12.45 to 
18.04 uS), for 0 to 5 minutes after (13.84 + 8.51 uS , 95%CI: 11.28 to 16.40 uS), as well 
as 5 to 10 minutes after (14.07 + 9.23 uS , 95%CI: 11.30 to 16.84 uS). See Figure 1 for a 
visual description of GSR values across testing points. When analyzed across the entire 
sample, CPMABS was 0.24 + 1.04 kgf (95% CI: -0.06 to 0.53kgf) while CPMPERCENT was 
7.73 + 21.00% (95% CI: 1.76 to 13.70%). Cortisol values were not statistically 
significantly different before and after the CPT (Table 2). 
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Meaningful CPM  
The reliability for baseline PPDT was (ICC3,1), which was 0.97, indicating an excellent 
level of reliability based on the recommendations from Shrout & Fleiss.21 Thus, for this 
study the SEM of PPDT was 0.39 kgf. Accordingly, participants who had greater than a 
+0.78 kgf (or +18.3% of baseline mean PPDT)) increase in PPDT were termed 
modulation, a decrease greater than -0.78 kgf (or -18.3% of baseline mean PPDT) were 
termed facilitation, and participants who experienced anything between were described as 
having experienced non-response. 15 participants (30%) experienced inhibition of their 
pain thresholds, 6 participants (12%) experienced facilitation, while the remainder had no 
significant change of their PPDT values (58%). See Table 3 for a full description of 
PPDT and CPM values within these sub-groups (inhibition, facilitation, and non-
response).  
Associations with Indicators of Stress 
When disaggregated by class, there was a moderate positive correlation ranging from r = 
0.63 to 0.69 (p<0.011) between CPM (CPMABS or CPMPERCENT) and the absolute change 
in GSR from baseline to immersion, or from baseline to the immediate 5 minutes after 
immersion, but only in the 15 participants who experienced inhibition of their PPDT 
values. See Table 4 for a full description of the correlational matrix between CPM and 
stress measures in the inhibition group. Within the non-response group, there was a low 
negative correlation of r = -0.47 (p=0.01) between CPMABS and the absolute change in 
GSR from baseline to the immediate 5 minutes after immersion. There were no other 
statistically significant relationships within the non-response group. There was no 
significant relationship between CPM and any indices of SNS activity in the group that 
experienced facilitation. There were also no significant relationships between CPM and 
the change in salivary cortisol in any of the classes.  
2.4 Discussion 
The purpose of this study was to explore the associations between indicators of stress 
system reactivity (i.e., salivary cortisol, GSR) and meaningful CPM within healthy young 
adults in reaction to a standard experimental pain protocol using noxious cold (CPT). It 
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appeared that in reaction to the CPT, when analyzed as a group, there was no significant 
CPM effect, as PPDT values remained statistically unchanged. Salivary cortisol values 
also remained unchanged in reaction to the CPT. This was despite a statistically 
significant increase in GSR values at all timepoints compared to baseline, suggestive of 
an increase in sympathetic nervous system activity. When we evaluated for meaningful 
CPM in relation to + 2 SEM, a majority of participants experienced no appreciable 
change of their PPDT (58%), while 30% of participants experienced the expected 
inhibition (i.e., increase in PPDT) of their pain sensitivity. Within this group of 
participants who experienced inhibition, there was a moderate positive association with 
the change in GSR, suggesting that pain modulation may be related to the magnitude of 
the stress response in reaction to the CPT in those who can suppress their pain 
experience.  
 
Approximately half of the current study’s participants were able to complete the full 90 
seconds of submersion for the CPT. Previous work by Kaunisto et al. (2013) found that 
24% of their sample could tolerate cold water immersion for the full 90 seconds, however 
this result may have been explained by the presence of chronic pain.19 One criticism of 
using cold endurance in this manner is the presence of a ceiling effect. However, as there 
were a large amount of participants in the present study and previous investigations19 that 
could not tolerate the full immersion time, 90 seconds of immersion may still be 
appropriate. Future work is required to establish an upper limit on CPT immersion time. 
 
There is a growing body of evidence that PPDT inhibition in CPM protocols is not a 
universally experienced phenomenon even in healthy participants, and our results are in 
agreement with the literature. Locke et al. (2014) first evaluated CPM with respect to 1 
SEM of their testing stimulus (PPDT), finding that 92% of participants experienced an 
inhibitory CPM effect in reaction to the CPT as a conditioning stimulus.23 However, this 
analysis was only conducted on a pilot of 10 participants. In contrast, Vaegter et al. 
(2018) found that only 62% of participants (total sample = 26 participants) experienced 
pain inhibition using cold water immersion as a conditioning stimulus and mechanical 
PPDT as the test stimulus, using 1 SEM of the test stimulus to classify participants as 
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responders.24 To help increase the confidence in true change, Kennedy and colleagues 
examined meaningful CPM in relation to + 2 SEM of PPDT (to reflect a 95% confidence 
interval), finding that 59% of participants (total sample = 50 participants) experienced 
inhibitory CPM in reaction to a cold conditioning stimulus, while up to 6% of 
participants experienced facilitation of their PPDT across testing paradigms.6  
 
As such, it appears that CPM responses can be categorized as inhibitory (i.e., increase in 
pain threshold), faciliatory (i.e., decrease in pain threshold), and non-response. Future 
work will be required to ascertain the individual characteristics of participants that lead to 
these responses, and to clarify which response could be predictive in the development of 
conditions like chronic pain.  Interestingly, it appeared that the participants who 
experienced inhibitory CPM in our study, had a lower PPDT at pre-test compared with 
those in the faciliatory CPM cohort who experienced a higher base PPDT. This may 
reflect that those who are able to experience CPM and exhibit efficient diffuse noxious 
inhibitory control have a reserve that they are able to use when exposed to a noxious 
stimulus. Previous work conducted by Grouper et al. (2019) also suggests that those who 
are less sensitive to pain, experience less pain inhibition following a CPM protocol.25 
Larger samples will be required to investigate these CPM responses with respect to 
individual variability.  
 
Our study suggests that there exists a relationship between pain modulation and 
sympathetic nervous system activity in participants who experienced inhibitory CPM, as 
the change in PPDT values were moderately positively correlated with the change in 
GSR values both during and after the CPT. This relationship was reversed in the 
participants who had a non-response of their CPM. This is somewhat unsurprising, as 
acute stress can lead to an increase in sympathetic nervous system activity,26 which may 
lead to stress-induced analgesia.27,28 The CPT as a physiological stressor has also been 
known to produce strong sympathetic nervous system activity.26,29 These findings are in 
contrast to those of Geva and colleagues (2018), who found a reduction in CPM  in 
participants who perceived themselves as having a high stress response.7 However, we 
did not evaluate the appraisal of each participant to determine whether or not they were 
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cognitively experiencing high or low stress. As such, cognitive appraisal of the situation 
could partially explain the 12% of participants in the present study who experienced 
facilitatory CPM. Geva and colleagues (2014) also suggested that pain inhibition may 
only result when there is a perceived risk of injury, and when risk of injury is low, 
hyperalgesia could result.30 In all likelihood, the relationship between inhibitory CPM 
and stress likely follows a curvilinear relationship compounded by the degree of 
physiological stress and cognitive appraisal of the stressor involved. Future work is also 
required to understand why a large percentage of subjects in both the present study and 
previous investigations experience non-response in terms of CPM. Despite previous work 
suggesting that individual factors (e.g., age, sex, attention, physical activity levels, and 
genetics) play a role in CPM,31 it is unclear how they factor into identification of 
meaningful CPM. 
 
Salivary cortisol levels of the participants in the study were elevated compared to 
normative values reported in the literature.32 One explanation for this may be that as the 
cohort consisted of graduate level students, higher levels of stress and anxiety may have 
been present leading to elevated salivary cortisol levels. We were also unable to detect a 
relationship between CPM and the change in salivary cortisol as an indicator of the HPA 
axis. There are various explanations for these findings. On one hand, as cortisol has been 
known to peak 10 to 20 minutes after an acute stressor it may be that our study protocol 
measured cortisol too early to detect true change.10,14 Additionally, we did not rigorously 
control for time of day for our data collection. To circumvent this issue, we examined for 
the relationship between the change in PPDT and salivary cortisol to evaluate the cortisol 
reactivity of each participant. Thus, we believe the first explanation to be the more 
plausible of the two. These findings taken together suggest that the SNS may be 
implicated in the pain inhibition response that in those experiencing inhibitory CPM after 
exposure to an acute stressor. It is also possible that since our CPT did not include a 





There are limitations that should be addressed in the present study. As subjects were 
aware of the impending pain from the CPT, it is possible that the expectation of pain 
impacted the salivary cortisol data collected. However, seeing as GSR values increased 
significantly after the CPT, we believe that this is unlikely. As mentioned earlier, we did 
not control for time of day which may have impacted the stress response of each 
participant. Future work will want to control the time of day where cortisol is collected to 
allow for more robust comparisons. Our also cohort consisted of university students who 
may have had similar psychosocial tendencies that influence the pain 
experience.33Accordingly, our results may not apply to people from different 
socioeconomic statuses or with poorer health literacy. Due to interference with our GSR 
measurement devices, a circulating pump was not used, and we accept that a warm 
envelope could have formed around each participant’s hand during the CPT. However, as 
almost half the sample could not tolerate the full 90 seconds of the CPT, we believe that 
it was sufficiently painful to induce a CPM effect. As the present study is cross-sectional 
in nature, we were unable to explore any causal relationships between CPM and GSR. It 
should be noted that CPM protocols have been known to vary across different 
investigations, using different conditioning and testing stimuli.4,34As such, it is unclear if 
the results of our study would have varied had used a different CPM protocol. Sequential 
evaluation of the test stimulus has been suggested to be a better representation of CPM 
responses as it may be less prone to distraction than parallel designs.35 However, future 
work is required to determine both the most appropriate conditioning stimuli as well as 
the timing of the test stimulus is CPM studies.  
2.5 Conclusion 
In conclusion, only 30% of healthy adults in our study experienced inhibition of their 
pain threshold in reaction to a CPT. This appeared to be associated with an increase in 
sympathetic nervous system activity, as measured by GSR, but was not associated with 
cortisol reactivity. Further work is required to examine for the presence of other 
individual variables which may contribute to the experiences of the various CPM 
responses (such as cognitive appraisal). Future research may also want to identify which 
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Table 1: Participant Characteristics. Data are presented as mean + standard 
deviation. Range is provided in brackets where applicable. 
 Males  Females Total 
Sample Size (n) 25 25 50 
Age (years) 24.2 + 3.9 (18-35) 24.8 + 3.9 (21-30) 24.5 + 3.2 (18-35) 
Height (cm) 178.6 +  7.2 (167.6-194.0) 166.3 + 7.4 (149.9-177.8) 172.5 + 9.5 (149.9-194.0) 
























Table 2. Descriptive values for group PPDT, CPM, Salivary Cortisol, and GSR 
before and after CPT. Data are presented as mean + standard deviation. A 95% CI 
is provided in brackets. 
 Baseline After CPT 
PPDT (kgf) 4.31 + 2.03 (3.70 to 4.90) 4.57 + 2.20 (3.92 to 5.23) 
GSR(uS) 6.13 + 8.96 (3.50 to 8.76) 12.92 + 9.46 (10.14 to 15.70) 
Salivary Cortisol (ng/ml) 27.32 + 11.32 (24.11 to 30.54) 28.17 + 12.20 (24.71 to 31.64) 
Note: PPDT: Pain pressure threshold; CPM: conditioned pain modulation; kgf: kilograms of force; GSR: Galvanic Skin Response; uS: 

























Table 3. Descriptive values for PPDT and CPM within classification groups. Data 
are presented as mean + standard deviation. A 95% CI is provided in brackets. 
 Inhibition (n =15) Facilitation (n=6)  Non-response (n = 29) 
Baseline PPDT (kgf) 3.92 +1.85 (2.90 to 4.95) 6.29 + 2.90 (3.24 to 9.33) 4.09 +1.75 (3.42 to 4.76)  
Post PPDT (kgf) 5.34 + 2.62 (3.89 to 6.80) 4.99 + 2.54 (2.32 to 7.66)  4.03 + 1.73 (3.37 to 4.69) 
CPMABS (kgf) 1.42 + 0.82 (0.97 to 1.87) -1.29 + 0.74 (-2.07 to -0.51) -0.06 + 0.34 (-0.19 to 0.07) 
CPMPERCENT (kgf) 35.27 + 6.79 (31.51 to 39.04) -21.61 + 8.03 (-30.04 to -13.18) -0.44 + 8.78 (-3.78 to 2.89) 

























Table 4. Correlational matrix between CPM and stress response measures within 
the Inhibition group. 
 CPMABS CPMPERCENT ∆GSR (during CPT) ∆GSR (after CPT) ∆Salivary 
Cortisol 
CPMABS - 0.43 0.65** 0.63* 0.20 
CPMPERCENT - - 0.69** 0.65* 0.34 
∆GSR (during CPT)   - 0.96** 0.44 
∆GSR (after CPT)    - 0.35 
∆Salivary Cortisol     - 
Note: CPM: conditioned pain modulation; kgf: kilograms of force; GSR: Galvanic Skin Response; uS: microsiemens; ng/ml: 


















Figure 1. GSR values at each testing time point with 95% confidence intervals for 
entire sample of participants. * denotes significantly different from baseline values 
at p< 0.001. 
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Chapter 3  
3 Initial Tolerability and Reactions to a Novel Virtual-
Reality-Based Road Collision Simulator: An Exploratory 
Study 
3.1 Introduction 
Symptomology following a motor vehicle crash (MVC), has been a well-documented 
occurrence.1,2 Of these various symptoms, whiplash-associated disorders (WAD) 
represent a common and burdensome problem from many different contexts including 
social and personal costs.3 The symptoms of WAD can include but are not limited to: 
neck pain, loss of range of motion of the neck, neurological deficits, and even fracture of 
the cervical spine.4 However, despite the persistent issues associated with WAD, 
consensus regarding its etiology is far less certain.5,6 Many theories have proposed that 
the development of symptoms may be due to the biomechanical influences of the car 
crash, such as the speed or direction of impact.5,7 Other competing theories have 
suggested that the development of WAD in some cases is not due to biomechanical 
influences, but rather psychosocial factors including maladaptive beliefs and/or an 
exaggerated stress response to trauma.7,8 Unfortunately, many of these theories are 
difficult to investigate empirically as it is simply not ethical to place individuals in live 
car crashes nor has the manipulation of car crash parameters under controlled 
circumstances been feasible.9 
Accordingly, Virtual Reality (VR) has emerged as a technology through which otherwise 
dangerous situations such as MVCs can be simulated without the risk of biomechanical 
injury causing tissue damage.9 Recently, VR has been leveraged as a means to create pain 
distraction, improve neck range of motion, and to engage adolescents in physical activity 
through exergaming.10–12  VR is usually achieved through the combination of a head-
mounted display (HMD), head/limb tracking hardware, and a powerful computer to 
create an immersive three-dimensional environment.13 The creation of an immersive 
three-dimensional virtual environment can help to create a sense of presence in said 
environment, which has been defined as the psychological sense of ‘being there’.14 
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Traditionally, the sense of presence is amplified by enhanced virtual interactivity, greater 
visual vividness, and multi-sensory input while it is diminished by feelings of simulator 
sickness and an awareness of the apparatus being used.15,16 
We have created an immersive Virtual Reality (VR)-based road traffic collision simulator 
that also interfaces with a programmable 6 degrees of freedom robotic platform. While 
other such driving simulators exist, (to our knowledge) ours is the first where a virtual 
collision is the main intent.17,18 Also, while previous research has demonstrated the 
effects of placebo car crashes in lab settings,5 ours was specifically created to immerse 
participants in a scenario designed to imitate the settings of a real-world MVC and elicit 
feelings of presence. A VR environment that is designed to mimic emotional or stressful 
environments (i.e., MVC) may elicit greater feelings of presence, and thus may be more 
appropriate to explore the sensation of involvement in a MVC than traditional laboratory 
settings.19 MVC’s are considered to be a unique stressor in adult life, that can lead to 
feelings of sudden chaos and a fear of safety, all of which may act as a catalyst toward 
the development of WAD.7 Thus, the purpose of this study was to explore the tolerability 
of using a VR road collision simulator, to gather user feedback for optimization, and to 
examine the development of any adverse events (i.e., reports of neck pain longer than 48 
hours, vomiting, inability to tolerate VR, disorientation). Exploration of development of 
symptoms following exposure to the VR platform was also deemed relevant as previous 
research has highlighted the possibility of symptom development following exposure to a 
placebo car crash.5 
3.2 Methods 
This was a cross-sectional exploratory study with a pre-to-post design. 
Participants 
Healthy participants were recruited from the community via email and word of mouth at 
Western University between October 2020 and January 2021. Eligible participants were: 
18 years or older, otherwise healthy with no recent (3 months) significant trauma or 
injury that required medical care and were able to read and understand conversational 
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English. Exclusion criteria were recent neck pain, headache, concussion, cardiovascular 
instability (e.g., heart disease, high or low blood pressure), were actively undergoing 
cancer treatment, neurological or systemic conditions that affect balance or postural 
control (e.g., Benign paroxysmal positional vertigo), migraines, visual pathology (e.g., 
saccades), technophobia, and claustrophobia.  Subjects also had to pass a cervical 
dysfunction clearing test performed by one of the primary investigators (M.J.L). 
Secondary to the COVID-19 pandemic, participants also had to complete a standardized 
questionnaire examining their suitability to return to campus and also had to have their 
temperature checked and screened prior to participation. This study was approved by the 
Health Sciences Research Ethics Review Board at Western University (London, ON, 
Canada) prior to participation in the study and all participants provided written informed 
consent prior to participation.  
The VISION System 
The VISION (Virtual Interface for Stress-Trauma Interactions through Open World 
Navigation) system is comprised of a HTC Vive (HTC Corporation, Xindian City, 
Taipei) head mounted VR display (HMD), noise cancelling headphones, and a Mikrolar 
R3000 (Mikrolar Inc., Hampton, NH, USA) robotic platform. The virtual environment 
these hardware peripherals interface with depicts a simulated car ride through a city. The 
visuals of this simulation are delivered by the onboard screens of the HMD which also 
tracks the participant’s head position via two fixed infra-red base stations, allowing the 
participant to examine 360 degrees of their surroundings from the passenger seat of the 
moving vehicle (Figure 2). To maintain a heightened sense of immersion, the 
simulation’s audio is delivered by a set of noise-cancelling headphones such the volume 
of all external audio sources is reduced, further emphasizing the sounds of the virtual 
environment. Lastly, the simulation is designed such that the movements of the 
participant’s virtual car are synchronized with a robotic platform which can be controlled 
along six programmable degrees of freedom: the x-,y-, and z-planes as well as yaw, pitch 
and roll (Figure 1). Prior to the collision, the robotic platform will simulate the feeling of 
acceleration and deceleration by modulating its yaw, pitch, and roll to match that of the 
virtual car. At the moment of impact, the VISION system also delivers a perturbation to 
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its occupants based upon the type of crash selected (rear-end, side-impact, or front-end). 
Instructions provided to the robot were designed to not accelerate beyond 1g for any of 
the crash scenarios; for reference the head and neck experiences 1 to 3 g of acceleration 
during sneezing.20  On pilot testing we determined that for the rear crash scenario the 
peak accelerations at the head were no greater than 0.2 g. It should also be noted that the 
cervical spine regularly experiences such accelerations (1 g) in daily life without 
provoking symptoms.5  
The VISION system is capable of 12 different crash scenarios, each of which can be 
altered via the following crash parameters: the type of crash encountered (rear-end, side-
impact, or front-end), amplitude of perturbation (low or high), time of day (night or 
dusk), weather (rain or clear skies), seat position (front passenger, or right/left rear 
passenger), audio selection (no music or various musical selections), whether or not the 
glass of the car shatters upon impact, and whether or not the participant receives audio 
indication that a collision is to take place (e.g. lights and horn of colliding vehicle). For 
the purpose of this initial exploration of tolerability to the system, participants were 
exposed to a low speed rear-end collision at night under clear weather while they sat in 
the front right passenger seat with no music playing. The windshield glass of the virtual 
car was set to shatter and the participant received an audio indication that a crash was 
imminent via a simulated car horn played through the earphones. These parameters were 
selected as they were thought to be the least provocative in nature yet mirror those in 
rear-end MVCs, for which development of whiplash injuries has been reported to be the 
most common.21,22 
Experimental Protocol 
Prior to their visit with the research team, each participant completed a study-specific 
demographic questionnaire indicating their sex and age. Each subject also completed the 
state version of the State-Trait Anxiety Inventory-6 (STAI-6)23 to assess general anxiety 
as well as the Fear of Pain Questionnaire–9 (FPQ-9)24 to assess fear of pain. The FPQ-9 
is a shortened version of the FPQ-III which has demonstrated good psychometric 
properties. The FPQ-9 consists of 9 items scored on a 5-point Likert-scale, with higher 
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summed scored indicating higher fear of pain.24 The FPQ-9 also has three subscales 
which can be calculated: Fear of Severe Pain, Fear of Minor Pain, and Fear of 
Medical/Dental Pain.24 The STAI-6 consists of 6 questions measured on a 1 to 4 Likert-
scale and has been determined to provide similar results to that of the full 20-item 
STAI.23 Each question is summed with higher scores signifying greater anxiety ranging 
from a minimum of 6 to a maximum of 24. For comparison to norms, the total score was 
divided by six, and multiplied by 20 to generate a pro-rated score from 20-80 as would be 
obtained from the full version.25 STAI scores can be interpreted as ‘no to low anxiety’ 
(20-37), ‘moderate anxiety’ (38-44), and ‘high anxiety’ (45-80).26 
For the hour before the study, each participant was advised to refrain from any eating, 
drinking, or physical activity.  After having their cervical spines screened, and sitting 
quietly for five minutes, each subject sat in the VISION simulator during a non-crash 
route for five minutes to become acclimatized to being in a virtual reality simulation and 
to judge the immersion of the simulator. This non-crash route involved sitting in the front 
right passenger of a virtual car with it making four turns around a city block with no 
crash. Seat height of each participant was optimized to their respective height based on 
personal preference, the time of day was set to night, and no in-simulator music was 
playing. Each subject was allowed to survey their virtual environment as much as they 
wished during the virtual drive. Following the five minute acclimatization period during 
the non-crash route, subjects were given a minute of rest prior to the next simulation. 
This rest period consisted of removal of the VR-headset, but participant remained in the 
seated in the robotic platform. Immediately following the non-crash simulation, each 
participant was informed that the subsequent simulation would include a virtual car crash 
but were not told when or where (i.e., rear-end collision) it would transpire. Each 
participant was then exposed to the low-speed rear end collision through the VISION 
platform, that occurred after approximately 1 minute of simulated riding in the virtual 
car. During the crash the robot delivered a small anterior perturbation (<1 g) to the 
participant through the car seat to further the immersion of the simulation. Afterwards, 
the participants dismounted from the simulator, and were observed for five minutes to 
monitor for the presence of any immediate adverse events.  
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Sense of Presence and Simulator Sickness 
After this period each participant completed the Presence Questionnaire (PQ),27,28 and the 
Simulator Sickness Questionnaire (SSQ)29 to gather initial feedback regarding the 
immersion of the VISION simulator and to capture any adverse reactions. The PQ has 24 
items from 1 to 7 on a Likert scale designed to measure the degree to which a participant 
feels immersed or present in a virtual simulation. Each item from the Presence 
Questionnaire is summed with higher scores representing greater immersion.27 The 
individual items from the PQ can also be summed to produce summary scores in the 
following categories: Realism, Possibility to act, Quality of interface, Possibility to 
examine, and self-evaluation of performance.27 For the present study, questions 20 to 24 
were pertinent to sounds and haptic and such were excluded from the study as they were 
deemed not immediately relevant before study commencement. The 19-item version of 
the PQ with a maximum score of 133 was selected over the original 32-item 
questionnaire due in part to its shortened length and good internal consistency.27,28  
The SSQ is a 16-item survey with responses ranked from 0 to 3 points.29 The 16 
symptoms are placed into three categories (Oculomotor, Disorientation, and Nausea) with 
unique weights attached and summed to produce a total score, with higher scores 
indicating a greater degree of nausea with a maximum score of 235.62.29,30 Total scores 
above 20 have been suggested to indicate ‘sufficient discomfort’.31 Each participant was 
instructed to follow-up with the research team should they develop any adverse events 
that lasted beyond 48 hours following the protocol. 
Statistical Analysis 
Descriptive statistics, including mean, standard deviation and range, were calculated for 
participant demographics, STAI (pre and post-simulation), SSQ and PQ scores (as well as 
their subscales). Data were visualized via box-and-whisker plots and outliers were 
identified through visual and statistical tests of normality. The majority of the measures 
were non-parametric in nature (Kolmogorov-Smirnov tests). Individual items from the 
PQ and SSQ were critically examined independently in order to determine the usability 
of the VISION platform and to ascertain areas for improvement. SSQ items were 
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recorded as a percentage of the total sample to understand incidence for each of the 
scores (i.e., none, slight, moderate and severe). As the PQ items do not have a descriptor 
for each part of the scale, individual items were examined descriptively (mean + standard 
deviation). Adverse events were recorded throughout the protocol as incident counts of 
reported neck pain longer than 48 hours, immediate vomiting, inability to tolerate the 
simulator, and self-reported disorientation post-protocol. A Wilcoxon-signed rank test 
was used to examine differences in STAI-6 scores from before and after exposure to the 
simulator. Spearman’s correlations were used to examine for relationships between SSQ, 
STAI-6, FPQ, and PQ scores. Strength of Spearman correlations were interpreted as:  
<0.30 (negligible), 0.30 to 0.50 (low), 0.50 to 0.70 (moderate), 0.70 to 0.90 (high), >0.90 
(very high).32 All analyses were conducted using IBM SPSS Version 27, and the level of 
significance was set at p<0.05.  
 
Sample Size Calculation 
As this research project was exploratory in nature, no formal sample size calculation was 
performed, though a small sample of  as little as 20 participants has been suggested as 
appropriate for exploratory studies.33 A sample of 25 participants was deemed to be 
sufficient in order to ascertain an initial impression of tolerance to the VISION simulator 
and to determine to areas of improvement while minimizing risk of exposure to this 
potentially provocative scenario. 
3.3 Results 
Participants 
25 healthy participants (16 male, 9 female) with no recent (3 months) significant trauma 
or injury that required medical care participated in the study. The mean age of the group 
was 27.3 + 4.1 years (Table 5). All subjects successfully completed all aspects of the 
protocol and there were no verbal reports of nausea, inability to tolerate VR, and 
complete disorientation in response to the virtual simulation. There were no reports of 
neck pain immediately after the simulation. One subject did report neck pain on the day 
immediately after the virtual simulation but their symptoms only lasted one day. No 
medical follow-up was required. Total FPQ-9 scores were similar to those reported in 
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previous investigations into otherwise healthy participants.34 STAI-6 scores prior to the 
simulation indicated ‘high anxiety’ prior to the simulation. There were no significant 
differences between STAI-6 scores from before (46.53 + 6.05 ) and after (44.27 + 5.14) 
the VISION simulator. 
 Simulator Sickness and Sense of Presence 
Results for the Simulator Sickness Questionnaire and Presence Questionnaire and their 
subscales (mean + standard deviation, range) are presented in Table 6. In terms of 
Simulator Sickness, the mean total score was 23.49 + 21.98 (0.00 to 89.76) out of a 
possible 235.62 indicating sufficient discomfort. The majority of participants indicated 
none to slight for each item of the SSQ with twelve participants reporting moderate 
severity of a number of symptoms including nausea and fatigue, and only one participant 
indicating severe symptoms (eye strain) (Table 7).  In terms of feelings of presence and 
immersion, the mean of the total PQ score was 91.04 + 14.08 (54.00 to 112.00) out of a 
possible 133. Participants rated the ability to control events (mean 2.04 out of 7.0), 
environmental responsiveness (mean 3.4 out of 7.0) least favorably compared to the 
remainder of the PQ items (mean 5.0 out of 7.0; Table 8).  
 Correlation Analysis 
A significant low negative correlation (r=-0.40 to -0.49) was observed between the Self-
Evaluation subscale of the PQ and the SSQ total score, as well as its Nausea and 
Disorientation subscales. There was no significant correlation observed between the PQ 
and SSQ total scores. There was a significant low negative correlation (r=-0.41 to -0.48) 
between Post-simulation STAI-6 scores and SSQ total score, as well as its Nausea and 
Disorientation subscales. A full description of the correlation analyses is presented in 
Table 9.  
3.4 Discussion 
The purpose of this study was to explore initial user reactions to a novel virtual reality-
based road collision simulator for empirical investigation into potential mechanisms of 
WAD. We also sought to screen for the presence of any adverse events in reaction to the 
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VISION simulator. Our study demonstrated that exposure to a VR-based MVC was well 
tolerated by a majority of participants, although one participant reported neck pain the 
following day, which did not last longer than 24 hours. There appeared to be a negative 
relationship between sense of presence and simulator sickness, specifically between the 
Self-evaluation subscale of the PQ and the SSQ total score as well as the Disorientation 
subscale of the SSQ. This relationship may indicate that as a participants sense of 
presence increases, they experience less feelings of simulator sickness.  
 One subject reported severe eye strain in reaction to the simulator; otherwise, the 
simulator was well tolerated across all other items of the SSQ. The mean SSQ score was 
23.49 + 21.98, which based on previous research, indicates ‘sufficient discomfort’.31 
However, SSQ score interpretation has faced some contention as the cutoff score of 20.0 
has been criticized as too strict in the context of non-aviation VR simulations, nor is it 
recommended to interpret scores compared to the maximum possible score (235.62). 35 
That being understood, as the majority of the items on the SSQ were rated as ‘None’ or 
‘Slight’, we are reasonably confident that we can conclude that the VISION platform was 
tolerated well enough. There were no adverse events recorded in reaction to the 
simulator, allowing us to conclude that the use of VR-based road collision simulator can 
be safely used to simulate rear-end MVCs in a controlled fashion.  
One of the 25 participants (4%) in the present study reported neck pain following 
exposure to the novel VR-based MVC. We are confident in saying that this was not due 
to the perturbation delivered by the VISION platform, as the peak accelerations were 
magnitudes lower than those encountered in daily life. The peak accelerations of the 
VISION platform were also lower than that of those reported by Fice et al. (2019) who 
simulated laboratory based rear-end collisions without VR with peak accelerations of 
2.1g seemingly without incident.36  However, this finding of neck pain stands in stark 
contrast to the findings of Castro et al. (2001), who found that approximately 20% of 
their sample developed whiplash like symptoms in exposure to a placebo car crash.5 
There could be multiple explanations for this finding. In our study, one explanation is that 
participants were aware that the VISION platform was a simulator, and in essence a 
video game compared to the real world objects were used to provide a placebo car crash 
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in the study by Castro et al. (2001).5 However, as VR has been previously used 
successfully to treat posttraumatic stress disorder following a MVC,18,37 it appears that 
VR is able to replicate near-real virtual representations of traumatic scenarios.38 While 
the present study was not able to effectively confirm the development of WAD in 
reaction to a VR-based MVC, it also is not able to refute the theory either. Future work is 
needed to clarify the development of WAD-like symptoms from simulated collisions. 
While our PQ total score (68.4%) was lower than the clinically acceptable amount for 
VR-based driving simulators for VR-based exposure therapy (80%), we believe that with 
further refinement PQ scores will improve which may lead to higher incidences of self-
reported neck pain and/or other symptoms.39 Another possible explanation for the 
discrepancy between our findings and that of Castro and colleagues is that the sample in 
our study was much more limited than Castro et al. (2001).5 The psychological profile of 
our sample was limited to university students aged 18-35 and may not have included 
participants with a higher tendency for psychosomatic disorders who may be a higher risk 
for WAD-like symptoms from a simulated MVC without biomechanical potential for 
injury.5 
As the VISION platform is a prototype for simulation of MVCs, visual fidelity of the VR 
may be partially to blame for the lower-than-desired presence scores. There were 
occasional visual ‘skipping’ or ‘lag’ episodes where the framerate of the virtual display 
would drop to an unrealistic level. These episodes may explain why subjects rated the 
responsiveness of the virtual environment lower on the PQ but are expected to improve as 
the framerate of the VISION platform is optimized. These issues may also partially 
explain the statistically unchanged STAI-6 scores from pre- to post- exposure. As higher 
levels of anxiety have been associated with increased presence,40 it stands to reason that 
as the visuals and responsiveness of the VISION platform improve, STAI scores post 
exposure should also reflect greater anxiety. It should also be noted that this line of 
research was conducted during the COVID-19 pandemic, and as such there may have 
been influences on baseline levels of stress and/or anxiety that we could not control for.  
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There appeared to be an inverse relationship between both the sense of presence and 
simulator sickness as measured by the PQ and SSQ. This finding is in agreement with the 
findings of Weech and colleagues who conducted a scoping review in 2019, concluding 
that a majority of the available literature favors a negative relationship between the sense 
of presence and simulator sickness.41 However, these authors did conclude that this 
relationship is likely mediated by several factors such as sex, personality type, and 
previous gaming experience (for which we did not control). Lastly, oculomotor 
dysfunction can be one finding of WAD, even in patients who do not report symptoms.42 
As simulator sickness has been characterized by a predominance of oculomotor 
symptoms,41,43 it is unclear if simulator sickness is a prognostic indicator for those most 
likely to develop WAD.  As such, further investigation will be required to explore how 
high SSQ scores in otherwise healthy people may relate to the development of WAD 
following exposure to a simulated MVC.   
Limitations  
The sample size of this exploratory study was small and as such its conclusions must be 
interpreted with caution. However, this study sought to seek initial responses to a novel 
virtual car collision simulator and sought to explore initial reactions and the presence of 
adverse events. As such, we believe we were successful in this endeavor and that the 
results of the study will help to inform larger study designs in order to answer additional 
questions.  Another limitation with this work is that we did not control for multiple 
comparisons as the work was preliminary in nature. However, we feel that due to the 
exploratory nature of the research the results still hold merit and invite future 
investigation. As mentioned earlier, we also did not control for subjects with previous 
virtual reality experience nor did we control for participants who had been involved in 
previous car crashes. Both of these variables could influence the sense of presence and/or 
simulator sickness in response to the VISION platform. That being said, the results of our 
study are in agreement with previous literature highlighting a negative relationship 
between simulator sickness and presence. 
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Additionally, there were rare occurrences of the base stations losing track of the 
participant’s head in 3-D space. As a result, the system had to be re-set in order to re-
track the participant’s location. These tracking errors may have led to lower feeling of 
presence during the simulation. Again, with further refinement, it is expected that that the 
incidence of these episodes should be greatly reduced. The framerate of the VISION 
system also requires optimization. Lower frame rates could partially explain feelings of 
simulator sickness. Participants were also made aware that a collision would occur which 
may have influenced their reaction to the simulator. Lastly, we only used a small sub-set 
of the VISION platform’s settings. As such, it is unclear how the other settings (e.g., 
direction of impact, in-simulation music, awareness of impending collision) may impact 
stress, the sense of presence, and simulator sickness.  
3.5 Conclusion 
In conclusion, we have successfully created a virtual-reality based road collision 
simulator that is capable of simulating motor vehicle crashes under a controlled fashion 
for lab-based research. There were no adverse events, and all participants tolerated the 
VISION system well despite one participant reporting neck pain the following day. It 
appeared that the sense of presence may be negatively associated with simulator sickness. 
Sense of presence was not as high as we would have hoped, and opportunities for 
improvement include improvement of framerates to increase the responsiveness of the 
simulator, and better tracking of the HMD used in the simulator. Future research should 
examine the effects of combining simulator settings (e.g., front end collision with no 
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Table 5. Baseline Participant demographics. Data are presented as mean + standard 
deviation with range in brackets. 
 Total 
Sample Size (%female) 25 (36%) 
Age 27.3 + 4.1 (18-35) 
FPQ Total Score 18.88 + 4.41 (10.00 to 27.00) 
FPQFear of Severe Pain 9.20 + 2.43 (4.00 to 14.00) 
FPQFear of Minor Pain 4.64 + 1.35 (3.00 to 8.00) 




Table 6. Simulator Sickness Questionnaire and Presence Questionnaire results post 
simulation including subscales. Data are presented as mean + standard deviation 
with range in brackets. 
  
 Total 
SSQnausea 17.55 + 19.80 (0.00 to 85.86) 
SSQoculomotor 19.71 + 19.08 (0.00 to 45.48) 
SSQdisorientation 22.27 + 26.07 (0.00 to 97.44) 
SSQtotal 22.59 + 21.98 (0.00 to 89.76) 
PQRealism 33.28 + 6.69 (17.00 to 42.00) 
PQPossibility to act 15.36 + 4.48 (7.00 to 22.00) 
PQQuality 16.48 + 3.71 (6.00 to 21.00) 
PQPossibility to examine 14.44 + 2.97 (10.00 to 20.00) 
PQSelf-evaluation of performance 10.96 + 2.37 (5.00 to 14.00) 
PQTotal 91.04 + 14.08 (54.00 to 112.00) 
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Table 7. Simulator Sickness Questionnaire individual items analysis. Data are 
presented as percentages reported by total sample. 
Symptoms None Slight Moderate Severe 
General Discomfort 56% 40% 4% - 
Fatigue 76% 16% 8% - 
Headache 72% 28% - - 
Eye Strain 56% 36% 4% 4% 
Difficulty Focusing 60% 40% - - 
Salivation Increase 92% 8% - - 
Sweating 80% 20% - - 
Nausea 68% 24% 8% - 
Difficulty Concentrating 60% 40% - - 
Fullness of Head 80% 20% - - 
Blurred Vision 84% 16% - - 
Dizziness (Eyes open) 76% 20% 4% - 
Dizziness (Eyes closed) 92% 4% 4% - 
Vertigo 96% 4% - - 
Stomach Awareness 76% 20% 4% - 




Table 8. Presence Questionnaire individual items analysis. Data are presented as 
mean+ standard deviation. Each item was rated from 1 to 7, with higher scores 
representing increased immersion, but items 14, 17, and 18 are reversed.   
PQ Item Mean Score + SD 
1. How much were you able to control events? 2.04 + 1.40 
2. How responsive was the environment to actions that you initiated (or performed 3.40 + 1.85 
3. How natural did your interactions with the environment seem? 4.46 + 1.23 
4. How much did the visual aspects of the environment involve you? 4.32 + 1.34 
5. How natural was the mechanism which controlled movement through the environment? 4.60 + 1.26 
6. How compelling was your sense of objects moving through space? 5.04 + 1.14 
7. How much did your experiences in the virtual environment seem consistent with your real world experiences? 4.76 + 1.16 
8. Were you able to anticipate what would happen next in response to the actions that you performed?  4.00 + 1.91 
9. How completely were you able to actively survey or search the environment using vision? 5.92 + 0.86 
10. How compelling was your sense of moving around inside the virtual environment? 5.08 + 1.08 
11. How closely were you able to examine objects? 4.64 + 1.38 
12. How well could you examine objects from multiple viewpoints? 3.92 + 1.58 
13. How involved were you in the virtual environment experience? 5.20 + 1.22 
14. How much delay did you experience between your actions and expected outcomes? 5.42 + 1.32 
15. How quickly did you adjust to the virtual environment experience? 5.32 + 1.49 
16. How proficient in moving and interacting with the virtual environment did you feel at the end of the experience? 5.64 + 1.19 
17. How much did the visual display quality interfere or distract you from performing assigned tasks or required 
activities? 
5.32 + 1.46 
18. How much did the control devices interfere with the performance of assigned tasks or with other activities? 6.21 + 0.93 
19. How well could you concentrate on the assigned tasks or required activities rather than on the mechanisms used to 
perform those tasks or activities? 
5.88 + 0.97 
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Table 9. Spearman correlations between STAI-6 (Pre & Post), FPQ, PQ, and SSQ (as well as their subscales). 
STAI-6: State and Trait Anxiety Inventory – 6, FPQ-9: Fear of Pain Questionnaire -9, PQ: Presence Questionnaire, SSQ: Simulator Sickness Questionnaire 
* Significance at p<0.05; **Significance at p<0.01                                                                       
                                                                       
 Pre STAI-6 Post-STAI-6 FPQ-9 PQRealism PQPossibility 
to Act 







Pre STAI-6 - 0.35 0.10 0.02 -0.240 0.03 0.12 -0.24 -0.03 -0.18 -0.12 -0.09 -0.12 
Post-STAI-6  - 0.13 0.06 -0.28 0.11 0.11 0.20 0.01 -0.48* -0.37 -0.41* -0.46 
FPQ-9   - -0.20 -0.35 -0.19 -0.19 -0.22 -0.34 -0.02 -0.18 0.00 -0.07 
PQRealism    - 0.37 0.36 0.65** 0.63** 0.86** -0.34 -0.22 -0.20 -0.27 
PQPossibility to Act    - - -0.14 -0.01 0.32 0.45* 0.02 0.11 0.01 0.06 
PQQuality    - - - 0.51** 0.18 0.58* -0.13 -0.08 -0.01 -0.02 
PQPossibility to Examine    - - - - 0.31 0.60** -0.12 -0.02 -0.06 -0.08 
PQSelf-Evaluation    - - - - - 0.60** -0.49* -0.32 -0.40* -0.46* 
PQTotal    - - - - - - -0.34 -0.03 -0.1.6 -0.17 
SSQNausea    - - - - - - - 0.75** 0.68** 0.90** 
SSQOculomotor    - - - - - - - - 0.69** 0.92** 
SSQDisorientation    - - - - - - - - - 0.84** 



































Figure. Virtual display of participant while using VISION platform  3. Virtual display of part cipant while using VISION platform 
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Chapter 4  
 
4 Changes in Heart Rate Variability, Pressure Pain 
Threshold and Salivary Cortisol After Exposure to a 
Novel Virtual Reality-Based Motor Vehicle Crash  
4.1 Introduction 
The impact of whiplash-associated disorders (WAD) following a motor vehicle crash 
(MVC) are substantial, with both burden on the healthcare system and numerous personal 
costs.1 The symptoms of WAD vary, but commonly include both physical symptoms 
(e.g., neck pain) and psychological symptoms (e.g., post-traumatic stress disorder), often 
co-occurring.2 Despite its evident global burden, debate over the mechanisms for the 
development and maintenance of WAD has persisted, especially for the transition from 
acute to chronic symptomology.3,4 Previous literature has suggested that direction and 
speed of impact do not correlate with poor recovery,5 while other novel models of WAD 
have proposed that its development may be due to a dysregulated or maladaptive stress 
response to trauma.3,6 
In this context, the stress/startle reaction is considered any physiological change that 
indicates an increased sympathetic: parasympathetic tonal balance. In practice, this could 
be a sudden increase in somatic neuromuscular activity, change in heart rate, heart rate 
variability (HRV), or increased endocrine activity to protect against potential injury.7 
Autonomic dysregulation (i.e., sympathetic nervous system dominance) has been 
suggested as a further clinical feature of WAD and other persistent conditions (e.g., 
Concussion), for which there is symptom overlap.1,6,8 Endocrine abnormalities in the 
form of reduced cortisol reactivity have been implicated in patients with chronic WAD 
compared to healthy controls.9 Cortisol is a glucocorticoid hormone that is released in 
reaction to a stressor that aids with the restoration of homeostasis.10,11 Previous research 
has indicated a negative association between pain perception and cortisol levels, 
suggesting that increased pain sensitivity was found in participants with higher cortisol 
(Choi, 2012).10 HRV has also emerged as an objective measure for psychological stress, 
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as it provides non-invasive indication of both sympathetic and parasympathetic control of 
the body.12  
Autonomic dysregulation following a MVC has also been suggested to be related to pain 
inhibition.6,13 Decreased pressure pain detection threshold (PPDT) (or higher sensitivity 
to pain) locally at the neck has been reported in patients with both acute and chronic 
WAD, as well as impaired ability to modulate pain in the presence of a noxious stimulus, 
a process known as Conditioned Pain Modulation (CPM).13,14 Typically, a decrease in 
sensitivity to one pain stimulus (e.g. mechanical pressure) after exposure to a different 
‘conditioning’ stimulus (e.g. noxious cold) is classified as having experienced inhibition, 
while an increased sensitivity indicates facilitation.15 In other words, inhibition of PPDT 
represents an increase in pain threshold as measured by PPDT, while facilitation 
represents a decrease in PPDT. CPM is considered a quantifiable psychophysical test of 
nociceptive processing and has seen increasing use in pain research and practice owing to 
prior literature indicating that the nociceptive modulation is less effective, or perhaps 
even reversed (i.e., increased sensitivity to the testing stimulus after conditioning) in 
some chronic pain conditions.16 However, it is also unclear of exactly when increased 
pain sensitivity arises after trauma (i.e., immediately after or delayed onset) as sensory 
hypersensitivity has typically been investigated up to five weeks post-injury.17 
To date, the mechanisms of WAD have remained unclear, as previous longitudinal 
research has been forced to adopt an observational approach (as opposed to experimental) 
in order to understand what types of individuals develop conditions such as WAD.3,18 As 
a result, innovative research design has been called for to better assess the role of 
proposed theoretical models.3 Recently, we have developed a novel Virtual Reality (VR) 
and robot-based road collision simulator (see Chapter 3) designed to mimic the 
participant’s perspective of being involved in a MVC, without the potential for tissue 
damage from biomechanical forces. As a result, we are now poised to measure the 
physiological effects of VR-based MVC in real-time on healthy participants. Thus, the 
purpose of this study was to explore aspects of the physiological response to a novel 
Virtual Reality-based road collision simulator, using quantitative sensory tests (PPDT) 
and indicators of stress system reactivity such as heart rate variability (HRV) and salivary 
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cortisol. We also aimed to explore the use of the novel VR MVC simulator as a 
conditioning stimulus to examine its effects in eliciting a CPM response and any 
associations between the change in stress reactivity metrics and CPM.  
4.2 Methods 
Study Design 
This was an exploratory cross sectional study with a repeated measures design. 
Participants had baseline levels of PPDT, HRV, and salivary cortisol before and after 
exposure to VR-based MVC as described below. CPM was evaluated using a pre-to-post 
design for which the simulated collision was the conditioning stimulus.  
Participants 
A convenience sample of healthy adult participants was recruited via email and word of 
mouth at Western University between October 2020 and January 2021. Participants were 
eligible for participation if they were: 18 years or older, otherwise healthy with no recent 
(3 months) significant trauma or injury requiring medical care and could read and 
understand conversational English. Potential participants were excluded if they reported 
any pre-existing neck pain, headache, concussion, cardiovascular instability, active 
cancer treatment, neurological or systemic conditions that affect balance or postural 
control (e.g.,  Benign paroxysmal positional vertigo), migraines, visual pathology (e.g., 
saccades), technophobia, and claustrophobia. Secondary to the COVID-19 pandemic, 
participants also had to clear a standardized questionnaire examining suitability to return 
to campus and had their temperature screened prior to participation. This study was 
approved by the Health Sciences Research Ethics Review Board at Western University 
(London, ON, Canada) prior to participation in the study and all participants provided 
written informed consent prior to participation.  
Experimental Protocol 
Participants were asked to refrain from any strenuous physical activity and to avoid 
consumption of any food or drink (including caffeine) for the hour prior to data 
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collection. Participants completed a study-specific demographic questionnaire including 
details such as sex and gender identity. A three-lead set-up was used to capture the 
electrocardiogram (ECG) and the participants had the option of placing the electrodes 
(200 Foam Series, Cardinal Health) themselves using a figure for reference or the option 
of one of the primary investigators placing the electrode for them. After application of the 
sensors, participants sat quietly for five minutes in a comfortable chair in a climate-
controlled windowless room while HRV was continuously captured by proprietary 
computer software. Conditions in the lab were maintained as consistently as possible 
across participants and testing days (lighting, temperature, noise, etc.). HRV5min was 
evaluated, as five minute recordings are considered the minimum essential length of time 
for evaluation of HRV.19 During data collection of HRV, participants were asked to avoid 
talking or moving and to breathe otherwise normally. HRV was measured simultaneously 
using ADInstruments PowerLab (PowerLab®, ADInstruments, Sydney, Australia) at a 
sampling rate of 1000 Hz, with real time digitized and filtered data stored on a laboratory 
laptop.  
 
One saliva sample was collected near the end of the 5 minute rest period using a small 
poly-cotton swab that was rolled around inside the mouth for about 30 second before 
being sealed in a sterile salivette and immediately transferred to a -30C freezer. Next, 
pressure pain detection threshold (PPDT) was tested at the angle of the upper trapezius 
following a previously published protocol.20  In brief, the 1cm2 rubber tip of a digital 
algometer (FDX-25, Wagner Instruments, Greenwich CT) was pressed into the skin over 
top of the upper trapezius of the dominant side of the participant at a constant rate of 5N/s 
until they indicated that the sensation changed from pressure to pain. This was repeated 
three times, with a minimum 30 seconds between applications and the same rater 
conducted each test (MJL). The mean of the three trials (measured in kilograms of force 
(kgf)) was considered the PPDT. 
 
Each participant was then assisted into the VISION (Virtual Interface for Stress-Trauma 
Interactions through Open World Navigation) platform. A thorough description of the 
VISION platform is in Chapter 3 of this thesis. The VISION platform consists of a seat 
66 
 
affixed to a six degree of freedom robotic platform ((Mikrolar R3000 (Mikrolar Inc., 
Hampton, NH, USA)), a HTC Vive head mounted display (HTC Corporation, Xindian 
City, Taipei) with active noise cancelling headphones. During its use, subjects were first 
exposed to five minutes of driving in a virtual city as the passenger in the front seat of a 
virtual vehicle in an urban setting at dusk where they were able to view their environment 
as much as they wished but could not control the direction of speed of the vehicle. They 
were then given one minute of rest. The robotic platform was programmed to interface 
with the virtual reality headset such that movements of the virtual car were synchronized 
with the robot’s movements to add a proprioceptive experience to the visual and audio 
stimuli of being in a car. Subsequently, each participant was informed that the next 
simulation would have a virtual car crash but were not told when or where it would take 
place. In brief, subjects were exposed to a virtual reality based rear end collision that 
delivered a perturbation at a peak acceleration of 0.2 g (measured at the head) that 
coincided with the visual and audio indications of a rear end collision in the simulator 
(i.e., a second car approached and collided from the rear while the participant vehicle was 
stopped at a traffic light). Audiovisual stimuli included shattering glass of the windshield, 
squealing tires, a simulated car horn just before and after the collision, and no music was 
playing on the virtual car radio.  
 
Following exposure to the virtual collision, participants were assisted out of the VISION 
platform and the ECG leads were re-applied to their torso in the same fashion as the 
baseline measurements; the electrode placement remained unchanged. Participants sat 
quietly for 30 seconds prior to the re-evaluation of PPDT. PPDT was then measured 
immediately after exposure to the VISION platform serially in the same fashion as the 
pre-test for evaluation of any change. HRV was captured continuously throughout the 
post-exposure resting period for off-line analysis of recovery.  At the 5-minute post-
removal point, one more saliva sample was collected using the same poly-cotton swabs 
for post-exposure salivary cortisol. Each participant was also asked to return three to 
seven days later to recapture only the resting baseline PPDT and HRV. Salivary cortisol 





Descriptive statistics including mean and standard deviation of the sample were 
calculated for each variable after normality was assessed using Kolmogorov-Smirnov 
tests.  Outliers were removed and ratio level data were transformed if necessary, using 
logarithmic transformation. Data were presented in their un-transformed state to allow for 
easier comparison to the greater body of literature.  
 
HRV was analyzed over the five minute baseline period prior to the CPT and two five 
minute bins after (post-exposure and resting-state retest three to seven days later). A 
variety of HRV indices were selected in order to evaluate those best poised for further 
investigation in future studies. HRV indices were reported in Time domain parameters 
including root mean square of successive NN interval differences (RMSSD) and the 
standard deviation of the RR intervals (SDRR). For the frequency domains, HRV was 
analyzed with a high frequency (HF) band from 0.15 to 0.45 Hz and a low frequency 
band from 0.04 to 0.15Hz. HF and LF were both measured in absolute (us2) and 
normalized units (nu), as per the recommendations from the Task Force of The European 
Society of Cardiology.21 The ratio of LF/HF was also calculated, whereby a higher ratio 
indicates sympathetic dominance, and a low ratio indicates parasympathetic dominance.19  
 
Physiological Reactions to VISION Platform 
For purpose 1 (normative reactions to the VISION platform), mean PPDT and HRV were 
compared across testing times (T1 = 5 minute pre-simulation, T2 = 0-5 minute post-
simulation, and T3= 5 minutes retest 3 to 7 days later) using one way repeated measures 
analysis of variance (rmANOVA) with Bonferroni post-hoc to further explore significant 
main effects of time. Salivary cortisol (Cortisol (Saliva) ELISA, Alpco (Salem, NH, 
USA), cat no.11-CORHU-E01-SLV) was analyzed using industry standard approaches 
according to the manufacturer’s specifications and all samples were run in duplicate. 
Salivary cortisol was evaluated using the absolute difference before and after the 
exposure to the VR-based MVC to account for individual variation and a paired t-test was 
used to detect for significant differences.  A logarithmic transformation was applied to 
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HFms and LFms, as all other measurements were found to be normally distributed for 
parametric statistics.  
CPM Response 
For purpose 2, (CPM responses) CPM was recorded in both absolute (∆CPMABSOLUTE = 
Post - Pre simulation (in kgf)) and percent (%) change ((∆CPMPERCENT = 
∆CPMABSOLUTE/Baseline PPDT(kgf) x100)) terms, as per the recommendations of 
Kennedy et al., 2016.16 Meaningful CPM was evaluated using a similar approach was 
used to the work of Locke et al. 2014 and Kennedy et al., 2020.15,22 Next, the standard 
error of measurement (SEM) was calculated for PPDT ((SEM = pooled standard 
deviation of baseline PPDT (SDpooled)√(1-ICC)). Based on the work of Kennedy et al., 
2020, CPM was examined in relation to +2 SEM of baseline PPDT to reflect a 95% 
confidence interval in order to determine true change.15 This was then converted a 
percentage change based upon baseline mean PPDT. Both a percentage change and 
absolute change were included to reflect participants who may have experienced a small 
absolute difference, but large percent change compared to baseline testing. 
Relationship between CPM and Stress System Reactivity 
For purpose 3 (associations between CPM, change in HRV and salivary cortisol) 
Pearson/ Spearman correlations were used to explore the relationship between CPM, 
itself a metric of change, and change in the various HRV indices. Associations were 
explored with all HRV indices in order to target the ones best positioned for future 
studies. Strength of Pearson/Spearman correlations were interpreted using the 
recommendations of Mukaka (2012), whereby: <0.30 (negligible), 0.30 to 0.50 (low), 
0.50 to 0.70 (moderate), 0.70 to 0.90 (high), >0.90 (very high).23 Scatter plots were also 
used to both visually model and interpret the relationships of the data.  
All statistical analyses were completed using IBM SPSS Statistics Version 27 and the p-
value for statistical significance was set at 0.05. 
Sample Size Calculation 
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As this work was hypothesis-generating rather than hypothesis-testing, no formal sample 
size calculation was performed.  
4.3 Results 
Descriptive Statistics 
25 participants (16 males, 9 females) participated in the study and no participant in the 
study indicated their sex as different from their identified gender. As such, only male and 
female sexes are reported. The mean age was 27.3 + 4.1 (18 to 35) years. Demographics 
of the study population are displayed in Table 10. There was no attrition, as all 
participants returned for re-evaluation of their baseline measurements on the second 
testing day.  
 
Physiological Reactions to VISION Platform 
In terms of the time domain measures of HRV, RMSSD was significantly increased 
(p<0.002) after exposure to the VISION platform from 39.80 + 17.08 ms (95%CI: 32.75 
to 46.85ms) to 48.63 + 19.40ms (95%CI: 40.44 to 56.82). For the frequency domains, 
absolute high frequency power was significantly increased (p=0.004) from 900.96 + 
766.95 ms2 (95%CI: 33.22 to 47.68)  to 1262.96 + 853.38 ms2 (95%CI: 893.93 to 1631.99 
ms2)  after exposure to the VISION platform. Absolute low frequency power was also 
significant increased (p=0.004) after the VR-based MVC from 1534.42 + 1251.07 ms2 
(95%CI: 993.41 to 2075.42 ms2)   to 2108.87 + 1332.82 ms2 (95%CI: 1558.71 to 2659.03 
ms2). All other HRV indices at each time point are displayed in Table 11. There were no 
significant differences in any HRV measurement upon retest approximately one week 
later compared to baseline. Baseline values of PPDT were 3.36 + 1.14 kgf (95% CI: 2.89 
to 5.80 kgf) with no significant differences in values immediately after the VR MVC, or 
three to seven days later upon re-test. See Table 11 for a full description of PPDT values 
at these time points. Baseline levels of salivary cortisol were 31.57 + 13. 95 ng/mL (95% 
CI: 24.39 to 38.74 ng/mL) with no significant differences after exposure to the VR-based 
MVC. Cortisol data were only available on 17 participants because of COVID-19 related 
interruptions during the study period. 
CPM Response in reaction to VISION platform 
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When assessed as a group mean, CPMABSOLUTE was found to be -0.24 + 0.68 kgf (95% 
CI: -0.52 to 0.04 kgf) while CPMPERCENT was found to be -8.57% + 22.40 % (95%CI: -
17.82 to 0.68%) after exposure to the VISION platform. The reliability of PPDT in the 
present study was measured using intraclass correlation coefficient (ICC3,1) and was 0.96. 
For this study, SEM of the baseline PPDT measurements was 0.23 kgf.  Thus, it was 
determined that based on +2 SEM of PPDT any change in PPDT greater than + 0.47 kgf 
(or +13.9% of baseline mean PPDT) reflected inhibition, less than -0.47 kgf (or -13.9% 
of baseline mean PPDT) reflected facilitation, and in between these values reflected non-
response. After classification based on meaningful change of CPM >+ 2 SEM, it 
appeared that 16% (4/25) of participants experienced inhibition of their pain threshold, 
44% (11/25) experienced facilitation of their pain threshold, with the remainder 
experiencing no appreciable change. See Table 12 for a description of CPM within these 
groups. Using the CPM classification criteria, 16% (4/25) of participants still had a 
noticeably decreased PPDT compared to their baseline measurements one week prior 
upon re-test. 
Associations between CPM and Stress System Reactivity 
There was a statistically significant negative low correlation (r= -0.41, p=0.046) between 
CPMPERCENT and ∆RMSSD before and after exposure to the VR-based MVC (Figure 4). 
There was also a statistically significant negative moderate correlation (r= -0.64, 
p<0.001) between the ∆HF(ms2) and CPMPERCENT (Figure 5). Taken together, it appeared 
that that a decrease in pain thresholds (facilitation) was associated with an increase in 
parasympathetic nervous system activity. See Table 13 for a full description of the 
correlational matrix.  
There was a moderate negative correlation between CPMABSOLUTE and pre-post simulator 
change in salivary cortisol (r = -0.51, p = 0.035) (Figure 6). The association was 
maintained for CPMPERCENT (r = -0.59, p= 0.03) (Figure 7) reflecting that a decrease in 




The purpose of this study was to explore the range of physiological reactions after 
exposure to a novel VR-based MVC. We also explored the use of such a simulator in 
determining its suitability as a potential CPM protocol. Our study demonstrated that 
when analyzed as a group, while there was no significant changes in PPDT, there was a 
statistically significant increase in HRV indices (RMSSD, absolute HF, absolute LF) 
suggestive of an increase in parasympathetic nervous system post-exposure to a VR-
based MVC. This increase in parasympathetic nervous system activity appeared to be 
associated with greater sensitivity to mechanical pain (decreased pain thresholds). There 
was also a significant moderate negative association between CPM and change in 
salivary cortisol. When meaningful CPM was assessed as a change of PPDT greater than 
+ 2 SEM, it appeared that 44% of participants experienced actual facilitation (i.e., 
decrease) of their pain threshold in response to the VISION platform. Approximately one 
week later, up to 16% of participants continued to have a noticeably decreased PPDT 
measurement compared to their baseline levels.  
We were unable to demonstrate any autonomic system dysregulation following exposure 
to the VR-based MVC in the present study as evidenced by the non-significant changes in 
LF/HF. Baseline RMSSD values were within reported normative values from the 
literature.24 HRV indices were similar to those of baseline values post-exposure, however 
a statistically significant increase in parasympathetic nervous system activity was noted 
after exposure to the simulated collision. Previous investigations into the relationship 
between the autonomic nervous system and pain perception generally reflect that there is 
an increase in sympathetic nervous system activity associated with decreased pain 
sensitivity during an acute stressor – physical or mental.13,25,26 Unfortunately, due to the 
wired configuration of the ECG we used, we were unable to measure the effects of the 
VISION platform at the time of the virtual collision as the leads had to be removed to 
allow the participant to enter the simulator.  
We observed a low to moderate negative relationship between the percent change of 
CPM and change in HRV values measurement reflective of parasympathetic system 
activity after exposure to the VR-based MVC. Other studies have also investigated the 
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relationship between autonomic reactivity and CPM to various degrees, however most of 
these studies examine the relationship to resting HRV values. De Kooning et al., (2013) 
found no significant correlations between CPM values and HRV indices and concluded 
that autonomic reactivity and CPM appear to be unrelated.13 However, these authors did 
not explore the change in HRV as it relates to CPM which may explain the dissonance in 
findings. Koenig and colleagues (2016) did find a negative relationship between self-
reported pain and resting RMSSD values in healthy participants as opposed to chronic 
pain cohorts.27 Similarly, Nahman-Averbuch and colleagues (2016) also reported a 
negative correlation existing between CPM and resting HRV (measured with RMSSD) 
adaptations in men, but not women using tonic heat as a conditioning stimulus.28 Thus, 
there may be sex-related differences in the relationship between CPM and autonomic 
reactivity, however we were not sufficiently powered to explore this area. Sex-related 
differences in autonomic reactivity as it relates to CPM requires further investigations, 
especially given that WAD appears to affect a higher number of females than males.29 
Nonetheless, our study is not the first to report increased parasympathetic nervous system 
activity during recovery after exposure to an acute stressor. Mezzacappa and colleagues 
(2001) reported that in reaction to a mental stressor, healthy participants experienced a 
compensatory increase in RMSSD activity during recovery (also known as vagal 
rebound) that they postulated might be needed to recover from stress.30 Rat studies have 
also confirmed that exposure to repeated psychophysical stress leads to vagal rebound 
lasting beyond the duration of the stressor.31 However, other authors have suggested that 
while initial vagal rebound may be protective, prolonged exposure to stress may 
eventually elicit a maladaptive phase of parasympathetic withdrawal and sympathetic 
dominance.32 This speculation may also apply to individuals who are suffering from 
chronic WAD, as sympathetic dominance has been suggested to be a causal factor in the 
development of chronic pain.6,33 Mezzacappa and colleagues (2001) also suggested that a 
lack of or impaired vagal rebound following a stressor may reflect a failure of the 
parasympathetic nervous system to react, potentially increasing the risk for illness.30 
Given the various psychosocial stressors that can arise after a MVC (i.e., insurers, 
lawyers, and medical services),3 further research is needed to evaluate when and how 
parasympathetic recovery is altered following exposure to an MVC.  
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An interesting finding from this study was that there was a significant negative moderate 
association between CPM (absolute difference or percent change) and the change in 
salivary cortisol in reaction to the VR-based MVC. As a group, salivary cortisol was not 
significantly different after the VR-based MVC, but this may reflect that cortisol 
reactivity follows different patterns individually in reaction to a stressor. An explanation 
for the non-significant increase in salivary cortisol levels may be that we evaluated it too 
soon, as salivary cortisol levels have been known to peak after 10 to 20 minutes.34 Other 
authors have also examined for the relationship between CPM and salivary cortisol in 
healthy subjects. Timmers and colleagues (2018) found a positive correlation (r = 0.34) 
between change in PPDT and salivary cortisol using the Maastricht Acute Stress Task 
(combination of cognitive and physical stress) as a stressor.34 However, Hoegh and 
colleagues (2020) who also found a negative correlation between the change in salivary 
cortisol and PPDT using a cognitive Montreal Imaging Stress Test as a conditioning 
stimuli, whereby the change in cortisol could explain 19% of the variance in PPDT 
values.35 While we did not evaluate the role of cortisol in predicting PPDT values, it 
appears that elevated cortisol immediately after a mental stressor may be associated with 
decreased ability to modulate pain.35 Of course, due to mixed findings in the literature, it 
is likely that this relationship is dependent on the type of conditioning stimuli used. 
Larger studies will be required to investigate cortisol reactivity within meaningful CPM 
to further explore these relationships.   
Baseline PPDT values were higher than in previous investigations, possibly representing 
that the participants in the current study experienced some degree of hyposensitivity, and 
the SEM of baseline PPDT in the present study was similar to previous descriptions of 
PPDT in healthy participants.20,36 However, as baseline measurements of PPDT were the 
average of three measurements, we feel that regression to the mean cannot fully explain 
the change in PPDT values. Most interesting was that just over 40% of the participants 
included in this study had increased pain sensitivity of their trapezius muscles after 
exposure to the VISION platform. Thus, unlike a majority of CPM protocols, the protocol 
used in the present study did not encourage inhibition of pain thresholds, possibly 
indicating that it is likely not appropriate as a conditioning stimulus in CPM protocols.16 
However, there has also been debate over whether or not the conditioning stimulus in a 
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CPM protocol needs to be noxious in nature to produce modulation of pain thresholds.37 
For example, exposure to a mental conditioning stimulus (e.g., arithmetic counting) has 
also been shown to lead to pain inhibition.25 Most recently, Kennedy and colleagues 
(2020) evaluated the role of a sham conditioning stimulus (tepid water) in eliciting a 
CPM response in healthy participants.15 They also found that over 40% of their subjects 
experienced facilitation of their pain thresholds after exposure and concluded that 
expectation of pain may have contributed to this effect.15 Thus, it appears that CPM 
(either inhibition or facilitation) is dependent on the type of conditioning stimuli used as 
well as the potential contribution of expectation of pain.  
In the present study, we did not evaluate the role of expectation prior to exposure to the 
VR-based MVC, however each participant was informed prior to the exposure that a 
virtual collision would take place. A MVC is a traumatic stressor as evidenced by its own 
nomenclature reflecting the idea that these incidents are not merely accidents,38,39 and as 
such subjects could have anticipated that some degree of pain was expected. Therefore, 
expectation of pain and/or injury following exposure could at the very least partially 
explain the facilitated PPDT findings, though we are unable to fully account for them due 
to the sample size of the study. However, this line of thinking is in agreement with the 
findings of Bostick and colleagues (2009) who reported that even among healthy 
Canadians without previous injury, there was widespread pessimism regarding recovery 
after a potential MVC.40 As a MVC is a unique combination of physical and 
psychological stressors 3,41 it may very well be that the psychological exposure of being 
involved in a MVC (even a virtual one) can lead to an increase in pain sensitivity to the 
point that pain is perceived from relatively low biomechanical forces.42 If such findings 
are valid, both patients suffering from WAD and the clinicians treating them may have a 
better understanding of why some patients acquire WAD and some do not. However, 
further research is required to properly explore these theories.   
Limitations 
This study is not without limitations. Most noticeably, the sample size for the study was a 
small convenience sample of participants. As such, we were unable to explore the 
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relationships between the various measures of HRV (as well vagal rebound) and 
meaningful CPM within subgroup analyses with sufficient statistical power. That being 
said, this initial study was conceived as the beginning of a larger body of work exploring 
the range of physiological reactions to VR-based MVC’s without potential for tissue 
damage. We were also unable to capture HRV indices acutely during the virtual collision 
due to the physical constraints of our data capturing system and the physical space of the 
simulator. As such, we could not measure the effects of a virtual collision on HRV 
indices at the time of the collision and is an area for further improvement. While we did 
ask participants to refrain from any strenuous exercise or consuming any food or drink 
prior to study, we did not control for time of day which may have impacted the stress 
response of each participant. That said, most of the re-test data was conducted at a similar 
time of day to that of each participant’s initial data collection. Salivary cortisol data was 
also only available on 17 participants due to study interruptions because of the COVID-
19 pandemic. 
Due to the shorter time frames used for analysis, we were unable to capture other HRV 
indices. However, we are confident that the periods of analysis that we used were 
sufficient in order to explore HRV in the time and frequency domains selected. We also 
did not control for the breathing rate of each participant during HRV measurement. 
However, during these periods of time participants were instructed to breathe normally, 
and as such we do not believe that this would have influenced our results greatly. Also, as 
participants had their HRV measured in a seated position, there may have been increased 
contribution to the absolute LF values from the parasympathetic nervous system and the 
baroreflex.19 Thus, we may not have been able to accurately estimate sympathetic 
nervous system activity. Lastly, as this work was conducted on healthy participants, we 
were unable to make direct comparisons to patients with WAD, which is an important 
area for future investigation. 
4.5 Conclusion 
In conclusion, exposure to a VR-based MVC appears to have elicited an increase in pain 
sensitivity of the trapezius muscle in up to 44% of participants. In 16% of participants 
these effects persisted even up to three to seven days later upon re-test. It also appears 
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that a majority of participants experienced an increase in parasympathetic nervous system 
activity as measured by HRV after exposure reflecting vagal rebound which was 
associated with a decrease in pain thresholds. This line of work is envisioned as the first 
in exploring the range of physiological reactions to an otherwise safe and controllable 
MVC with little risk of actual tissue damage. Future work should examine the effects of 
exploring various simulator settings upon other physiological metrics as well as 
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Table 10. Participant demographics. Data are presented as mean + standard 
deviation with range in brackets. 
 Total 
Sample Size (%female) 25 (36%) 
Age (years) 27.3 + 4.1 (18-35) 
Height (m) 1.76 + 0.09 (1.57 to 1.93) 
















Table 11. HRV indices, PPT values, and salivary cortisol at baseline, post VR MVC, 
and upon retest. Data are presented as mean + standard deviation with range in 
brackets. 
 Baseline Post VR MVC Re-test (3 to 7 days) 
RMSSD(ms) 39.80 + 17.08 (11.26 to 86.75) 48.63 + 19.40 (15.43 to 85.89)* 39.30 + 16.36 (13.90 to 76.66) 
SDRR(ms) 57.30 + 22.53 (8.35 to 108.00) 64.47 + 22.92 (16.51 to 103.60) 57.48 + 18.36 (21.67 to 89.53) 
HF(ms2) 900.96 + 766.95 (34.50 to 
3615.00) 
1262.96 + 853.38 (55.26 to 
3529.00)* 
680.40 + 511.32 (76.14 to 
1834.00) 
LF(ms2) 1534.42 + 1251.07 (165.20 to 
4508.00) 
2108.87 + 1332.82 (345.10 to 
5350.00)* 
1557.37 + 979.01 (180.10 to 
3185.00) 
HF(nu) 38.01 + 19.76 (8.99 to 74.89) 38.99 + 17.26 (5.91 to 70.41) 36.01 + 17.38 (4.89 to 69.78) 
LF(nu) 59.76 + 22.79 (12.30 to 90.84) 57.20 + 20.46 (23.41 to 95.19) 62.33 + 20.49 (21.71 to 95.52) 
LF/HF 2.35 + 2.12 (0.16 to 9.30) 1.79 + 1.30 (0.33 to 4.67) 2.53 + 2.37 (0.31 to 9.82) 
PPT(kgf) 3.36 + 1.14 (1.31 to 5.80) 3.12 + 1.43 (0.84 to 6.56) 3.12 + 1.29 (1.28 to 5.55) 
Salivary cortisol 
(ng/ml) 
31.57 + 13.95 (15.30 to 65.81)  31.16 + 14.85 (12.13 to 65.06) N/A 
* Significance at p<0.05 compared to baseline 
Note: A logarithmic transformation was applied to HF(ms2) and LF (ms2) for statistical comparisons. RMSSD: root mean square of 
successive NN interval differences; SDRR: standard deviation of the RR intervals; HF(ms2):absolute high frequency; LF(ms2): 
absolute low frequency; HF(nu): normalized high frequency; LF(nu): normalized low frequency, LF/HF: frequency between low and 








Table 12. CPM expressed in absolute and percent change terms for all participant, 
inhibitors, facilitators, and non-responders. Data are presented as mean + standard 
deviation with range in brackets. 
 ∆CPMABSOLUTE (kgf) ∆CPMPERCENT(%) 
All Participants (n =25) -0.24 + 0.68 (-1.30 to 1.15) -8.57 + 22.40 (-52.30 to 36.64) 
PPT Inhibited (n=4) 0.76 + 0.30 (0.48 to1.15) 24.21 + 9.16 (15.76 to 36.64) 
PPT Facilitated (n= 11) -0.86 + 0.26 (-1.30 to -0.50) -28.30 + 12.53 (-52.30 to -15.45) 
PPT Non-Response (n=10) 0.04 + 0.38 (-0.39 to 0.76) 0.02 + 10.04 (-13.78 to 13. 10) 













Table 13. Correlational matrix between CPM and change in HRV indices and change in salivary cortisol 
 CPMABS CPMPERCENT ∆RMSSD ∆SDRR ∆HF(ms2) ∆LF(ms2) ∆HF(nu) ∆LF(nu) ∆LF/HF ∆cortisol (ng/ml) 
CPMABS  - 0.92** -0.34 -0.32 -0.46* -0.38 -0.11 0.11 0.08 -0.51* 
CPMPERCENT  - -0.41* -0.41* -0.64** -0.48* -0.17 0.17 0.12 -0.59* 
∆RMSSD   - 0.77* 0.43* 0.00 0.34 -0.30 -0.28 0.10 
∆SDRR    - 0.29 0.05 -0.01 0.03 -0.06 0.34 
∆HF(ms2)    - - 0.48* 0.48* -0.56** -0.66** 0.24 
∆LF(ms2)    - - - 0.44* 0.44* 0.42 -0.09 
∆HF(nu)    - - - - 0.89** -0.88** 0.06 
∆LF(nu)        - 0.92** -0.25 
∆LF/HF    
     
- 0.02 
∆cortisol(ng/ml)          - 
Note: CPMABS: absolute change in PPT values, CPMPERCENT: percent change in PPT values, ∆RMSSD: change in root mean square of successive NN interval differences; ∆SDRR: change in standard deviation of the RR intervals; 
∆HF(ms2): change in absolute high frequency; ∆ LF(ms2): change in absolute low frequency; ∆HF(nu): change in normalized high frequency; ∆LF(nu):change in normalized low frequency, ∆LF/HF: change in frequency between 
low and high frequency power. 





Figure 4. Relationship between Percent Change CPM and Change in RMSSD values 














Figure 5. Relationship between Percent Change CPM and Change in Absolute High 














Figure 6. Relationship between Absolute Change CPM and Change in Salivary 














Figure 7. Relationship between Percent Change CPM and Change in Salivary 
Cortisol before and after VR-based MVC. * Denotes significance at p<0.05. 
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Chapter 5  
5 Summary 
While it appears that acute pain may confer survival value in reaction to trauma, chronic 
pain may be best thought of as a disease where its effects are multidimensional, with 
interactions between biology, psychology, and social factors.1 This interplay between 
biological, psychological, and social factors in the context of Whiplash-Associated 
Disorders (WAD) may help to explain some of the heterogeneity in presentation.2 In 
development of this thesis, we approached WAD using the Integrated Model as proposed 
by Walton and Elliot (2017), whereby the motor vehicle crash (MVC) acts as a 
stressor/catalyst towards the development of WAD based upon the pre-existing 
vulnerabilities or protections (biological, psychological, social)  of the individual.3 While 
we did not examine for pre-existing protections and vulnerabilities, we still performed 
this research under the idea that a MVC is a unique and complex stressor that interacts 
with each person uniquely. Thus, the purpose of this thesis was to explore the complex 
relationship between pain and stress using a novel virtual reality (VR)-based road 
collision simulator which has been designed to explore the experience of being involved 
in a car crash, with comparisons to a known stressor (i.e., the cold pressor task). We 
viewed this work as exploratory and likely the beginning of a new research directive 
aiming to provide new avenues for exploring live, simulated traumas and to aid in 
developing the types of measurements that can be used with them. This project was also 
conceived as a means by which to begin to question why and how different stress 
responses occur, and we hope that this knowledge will begin to shed light on competing 
theories to explain such responses in the context of WAD.  
In Chapter 2, we sought to explore if meaningful CPM had relationships with both the 
sympathetic nervous system (SNS) and hypothalamus-pituitary-adrenal (HPA) axis 
reactivity in healthy adults following exposure to the cold pressor task. Healthy 
participants underwent evaluation of their pressure pain detection threshold (PPDT), 
conditioned pain modulation (CPM), galvanic skin response (GSR) and salivary cortisol 
both before and after a cold pressor test as a stressor (CPT). Meaningful CPM was 
evaluated based on change greater than or less than 2 Standard Error of Measurement 
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(SEM) of baseline PPDT to classify participants experiencing inhibition of pain, 
facilitation or non-response. When meaningful CPM was assessed, only 30% of 
participants experienced inhibitory CPM. Within this inhibitory CPM group, there was a 
moderate positive association between CPM and the absolute change in GSR as an index 
of SNS activity. In agreement with the literature, this work suggests that inhibitory CPM 
is not a universally experienced phenomenon and may be related to SNS activity. Future 
work may want to explore for various other individual factors that have been implicated 
in CPM using this meaningful CPM framework such as sex and age.  
In Chapter 3, we sought to evaluate initial tolerability to a recently developed novel VR-
based road collision simulator. This was done to gather user feedback for optimization, 
and to explore the development of any adverse events (i.e., reports of neck pain longer 
than 48 hours, nausea, inability to tolerate VR, and disorientation). Healthy participants 
had their state anxiety measured before exposure to a novel virtual reality-based rear-end 
collision simulator with a small perturbation (0.2 g) at the time of simulated impact. We 
also evaluated Simulator Sickness and Presence Questionnaires post-exposure. We 
observed that the VR-based MVC was well tolerated by a majority of participants while 
one participant (4%) reported neck pain the following day that did not last longer than 48 
hours. There were no other adverse events found. There appeared to be an inverse 
relationship between items on the Presence Questionnaire and Simulator Sickness 
Questionnaire (greater sense of presence, less experience of sickness or nausea). It 
appeared that a VR-based MVC could be safely used with healthy participants to model 
MVCs, but future work is required to optimize the VR environment and to investigate the 
effects of various crash parameters (e.g., direction of impact).  
In Chapter 4, we began quantification of the range of physiological responses to the novel 
VR-based road collision simulator. Healthy participants had their PPDT, heart rate 
variability (HRV), and salivary cortisol measured before and after exposure to a novel 
Virtual Reality (VR)-based rear end collision. Meaningful CPM was again determined 
based on baseline PPDT to classify participants as having experienced inhibition, 
facilitation, or non-response. There was an increase in HRV indices (root mean square of 
the successive differences (RMSSD) between normal heartbeats, absolute high 
92 
 
frequency), suggestive of an increase in parasympathetic nervous system activity after the 
virtual exposure, while PPDT values remained statistically unchanged based upon group 
means. When meaningful CPM was assessed, 44% of participants experienced 
facilitation of their pain threshold in following the VR-based MVC. There was a low to 
moderate negative association between the percent change in CPM and change in HRV 
(RMSSD, absolute high frequency) indicating decreased pain thresholds were associated 
with increased parasympathetic nervous system activity. There was also a negative 
moderate association between percent change CPM and change in salivary cortisol. It 
appeared that exposure to a VR-based MVC may increase pain sensitivity in some 
participants who are exposed, which may be related to increased cortisol reactivity or 
parasympathetic nervous system activity. Future work is recommended with larger 
samples for confirmation of these findings. 
While exposure to a cold pressor task appeared to induce decreased pain sensitivity in 
some participants with an associated increase in sympathetic nervous system activity, 
these findings were not replicated in a VR-based MVC. Instead, it appeared that there 
was an increase in pain sensitivity associated with increased parasympathetic nervous 
system activity and cortisol reactivity in the absence of injury-inducing biomechanical 
forces. In reaction to a stressor, post-traumatic stress research has described that there can 
be up to six different fear responses (which mainly present as sympathetic uproar and 
parasympathetic shutdown), though the time spent in each is dependent on the cognitive 
appraisal of the situation at hand.4 With the CPT, while participants are aware that the 
stressor will be painful, their perception of it its risks may be mitigated as they remain in 
control at all times during the immersion of their hand. In contrast, it could be that 
participants in our VR-based MVC experienced less locus of control, which in turn elicits 
a different stress response. Bolini and colleagues (2004) highlighted that in participants 
who had increased locus of control over a noise-cognitive paradigm, had a decreased 
cortisol response.5 Thus, we speculate that one of the major differences in these stressors 
and their associated stress/pain responses is the role of expectation of injury, despite not 
having measured it in this thesis. 
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It is our hope that by continuing to identify the myriad of stress and startle responses to 
simulated trauma, we may be better able to help identify the characteristics of individuals 
who are more likely to develop WAD such that treatment options can be better tailored to 
their care. While nervous system activity was measured differently across the two 
stressor studies, it is possible that the results of both studies are communicating similar 
findings. In reaction to the cold pressor task, participants who became less sensitive to 
pain experienced an associated increase in sympathetic nervous system. Comparatively, 
in reaction to a VR-based MVC, participants who became more sensitive to pain had an 
association with increased parasympathetic nervous system activity. Although not 
definitive, it appears that activation of the sympathetic nervous system after a trauma 
(simulated or otherwise), may lead to inhibitory pain modulation while activation of the 
parasympathetic nervous system, (or the absence of sympathetic tone) can lead to 
facilitatory pain modulation or heightened pain sensitivity. While it remains unclear if 
these nervous system activity patterns remain heightened for days after exposure, our 
results suggest that different physiological responses to trauma may be helpful in 
explaining the presence of alteration in pain sensitivity immediately following a stressor 
(both noxious or non-noxious). 
Taken together, our work suggests that the both the stress response and pain response to a 
given stressor is variable and appears to be based both on the individual’s appraisal of the 
stressor as well as the stressor selected. By removing participants from the VR-based 
MVC, it is possible that we provided a conditioned safety stimulus, which has been 
known to inhibit conditioned analgesia.4 In other words, the participant could have felt 
that they were immediately placed into a safe environment, thus leading to a recovery 
period of parasympathetic nervous system activity. Additionally, increases in SNS 
activity following the CPT could be explained by the presence of ongoing pain and or 
discomfort (even after its termination) signaling that ‘danger’ was still present. This 
thesis also suggests the possibility that some individuals who are exposed to a car crash 
may be at higher risk of pain and/or injury due to increased pain sensitivity resulting from 
the psychological experience of involvement in a MVC. In our society, a MVC may be 
considered a unique stressor due to its ability to create a fear of safety that is compounded 
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by the psychosocial impacts that present following the crash (i.e., litigation, ability to pay 
for services).3,6  
5.1 Future Directions and Questions 
As predicted, this thesis raises more questions regarding the relationship between pain 
and stress than it answers. These results have opened up discussion for identifying why 
some people develop WAD and others may not, but we recognize that future work is 
needed to continue to identify appropriate stress/pain responses to simulated trauma. This 
thesis presents the initial results and implications of the VISION project, and given the 
novelty of the VISION platform, we anticipate that there will be other future 
investigations into understanding WAD using controllable laboratory VR collisions. 
In the context of exploring the relationship between stress system reactivity and pain, we 
decided to explore these associations using simple bivariate correlations. However, after 
having performed this work we acknowledge that the relationship between stress and pain 
is likely a curvilinear relationship, and as such, future work will want to examine stress 
and pain from this perspective. Recently, Lee and colleagues (2021) investigated the role 
of blood-based protein/hormone biomarkers in the prediction of recovery following acute 
musculoskeletal trauma using a cluster analysis, as opposed to simple bivariate 
relationships.7 They found that in people with persistent disability there were also 
moderate to high levels of serum brain derived neurotrophic factor and transforming 
growth factor-beta 1. As such, the relationships between measurements of stress system 
reactivity (heart rate variability, salivary cortisol, galvanic skin response) and pain could 
be explored using such cluster analysis in future research to help predict recovery from 
trauma. 
While we chose to examine the immediate pain and stress response to controlled 
stressors, other research teams have spent great time trying to predict recovery from 
trauma. These investigations have appeared to consistently highlight three unique 
trajectory pathways: those very likely to recover, likely to recovery, and not likely to 
recover.8,9 At the same time, our work adds to the growing body of literature suggesting 
that Conditioned Pain Modulation (CPM) also consists of three unique responses, namely 
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inhibition, facilitation, and non-response.10,11 At this point, it is unclear if these three 
CPM responses align with trajectories predicting recovery. As interest in CPM as a 
biomarker for chronic pain continues to increase,12 future work may want to identify if 
these CPM responses can aid in identification of those likely to recover from trauma or 
not. Additionally, those investigating exercise-induced analgesia may want to evaluate 
meaningful CPM, as inefficient CPM and impaired exercise-induced analgesia have been 
linked in patients with other chronic conditions such as knee osteoarthritis.13 
One of the most surprising findings of this thesis was that that over 40% of healthy 
participants who were exposed to a virtual rear-end MVC exhibited increased mechanical 
pain sensitivity of their upper fibers of trapezius immediately post-collision. This finding 
is of particular interest as it may help to shed light on those participants who present with 
neck pain from low-speed collisions. It may be that the acquisition of neck pain following 
a MVC is due to a combination of the psychological exposure of the experience as well 
as any biomechanical forces imparted during said collision. As this finding was not 
replicated in all subjects, it is suggestive that there are different responses to being 
involved in a MVC which may help to explain the heterogeneity of WAD.3 Increased 
pain sensitivity may also have implications in the areas of recent imaging studies which 
have found fatty muscle infiltrate of the cervical musculature in chronic WAD 
patients.14,15 It may very well be that an immediate increase in pain sensitivity, 
compounded by the presence of biomechanical forces and/or other psychological 
stressors leads to a learned disuse of the neck musculature causing fatty muscle 
infiltration.15 Future work will want to examine increased pain sensitivity shortly after the 
time of injury to prevent these secondary sequelae from occurring. 
Lastly, this thesis only examined the effects of a rear-end VR-based MVC upon healthy 
participants. The VISION platform is capable of manipulation of collision type (e.g., 
rear-end vs front end) as well as other variables such as audiovisual knowledge of an 
impending collision. Future studies may want to manipulate these variables to gain 
further insight into the various pain and stress responses that may present in addition to 
examining how WAD patients may react to these stimuli. In the current study, we 
informed participants that a rear-end collision would occur, but did not say exactly when 
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it would happen. Future studies could attempt to manipulate the participants knowledge 
of the impending MVC to evaluate differential responses. For example, informing 
participants that a car crash would occur but not saying which type versus telling them 
exactly when the collision may take place would be of particular interest with respect to 
locus of control. Finally, to ensure that the simulator is adequately representing a MVC, 
qualitative inquiry with MVC survivors would be helpful to understand the experience of 
being involved in a MVC. Methodological approaches such as Qualitative Description, 
have been reported appropriate when specific descriptions of a phenomenon are desired 
and allow for a flexible yet simplistic approach to understanding such experiences, 
especially when there is a lack of information on a given topic.16,17 Qualitative inquiries 
would be helpful in continuing to understand why MVC’s and WAD affect different 
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Appendix C: VISION Pt. I Letter of Information and Consent 
Quantification of the stress response(s) and changes in conditioned pain 
modulation in reaction to the cold pressor task 
LETTER OF INFORMATION AND CONSENT 
Principal Investigator 
Dr. David Walton PT PhD 





Funding: Faculty Scholar Award & Chronic Pain Network Grant 
 
Dear Sir/Madam,  
 
Thank you for your time in reviewing this letter of information and for considering 
participation in our study. Please be sure you’ve read this letter in its entirety and have 
had any questions answered to your satisfaction before consenting to participate. 
 
Invitation to Participate  
 
You are being invited to participate in a study examining how pain can change following 
an acute stressful event. You are being invited because you have indicated that you are 
otherwise healthy and have had no recent trauma or injury affecting your muscles, joints, 
bones or ligaments in the previous 2 weeks. Furthermore, you are at least 18 years of age 
and are able to read and understand conversational English.  
 
In order to be eligible to participate, you must not have any of the following conditions. 
Please tell the research coordinator if any of these apply to you.  
 
1. Significant health conditions including infection or a history of cardiovascular 
instability (e.g., heart disease, high or low blood pressure) 
2. Actively undergoing cancer treatment  
3. Any health condition that affects your reaction to cold, including conditions such 
as Raynaud’s phenomenon or cryoglobulinemia  
4. Any health condition that impairs your ability to feel touch or temperature, 
including stroke, multiple sclerosis, amyotrophic lateral sclerosis, or nerve pinch 
in your neck.  
 
What the purpose of this study?  
 
We are evaluating how your sensitivity to pressure can be altered by a stressful event, and 
why that might occur. We will ask you to dip your hand into cold water (a task known as 
the Cold Pressor Task), which considerable prior research has used as a low risk and 
reliable way to create stress. We will also be examining the effects of some of your 
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personal attributes like your biological sex or gender orientation on your pain sensitivity.  
The results of this study will help us better understand the connections between pain and 
stress.  
 
How long will you be in the study? 
 
This study will occur over two 1-hour sessions separated by about one week (2 hours 
total commitment). 
 
What are the study procedures? 
If you agree to participate, the study will be conducted in the Pain and Quality of Life 
Integrative Research Lab (P.I.R.L.) located in Elborn College, Western University in 
London, ON. Prior to your visit you are asked to avoid eating, drinking sugary or 
caffeinated drinks or participating in vigorous activity for the hour prior. On each visit, 
the following procedures will occur:  
 
1. You will be asked to complete a few questionnaires. These will start by asking 
things about you: your age, height, weight, sex at birth, time you awoke that day, 
and the quality of sleep you had the previous night. You will also be asked to 
complete the Gender and Pain Expectation Scale that will ask you questions about 
how well different traits describe you and your beliefs about your sensitivity to 
pain compared to other people like you. Finally, you will be asked 6 short 
questions about your current level of anxiety.  
2. Next, the researchers will place recording electrodes on your chest to measure 
your heart rate, and on two finger tips of your non-dominant hand to measure 
your skin’s reaction to stress. You will have the option of placing the electrodes 
yourself according to a diagram or having the researchers do it for you. A 
standard inflatable blood pressure cuff will be wrapped around your upper arm. 
Then you will be invited to sit comfortably for 5 minutes while the researchers 
record data coming from the different sensors. At the end of the 5 minutes you 
will be asked to provide a small sample of saliva by placing a sterile cotton swab 
under your tongue for about 10 seconds before sealing it in a tube. It is important 
to note that none of the data we are collecting can be used for diagnostic purposes, 
however if your blood pressure should be very high, we will let you know and 
suggest some options you may wish to explore. Finally, your sensitivity to 
pressure will be tested by one of the researchers who will apply pressure using a 
battery-powered device with a small rubber tip with slowly increasing force until 
you indicate the sensation is painful. 
3. Next, you will be asked to submerge your dominant hand into a container of cold 
water (approximately 3-4 degrees Celsius) up to the wrist. During this time the 
researchers will continue to collect the information from the sensors connected to 
you. You will also be asked to rate your current pain on a scale of 0 (no pain) to 
10 (extreme pain) every 10 seconds. You are encouraged to keep your hand in the 
water for up to 90 seconds but may remove your hand at any point if you should 
choose to do so.  
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4. After your hand has been removed from the water and dried, the researchers will 
retest your pain sensitivity with the same rubber-tipped device. You will also be 
asked to provide one more saliva sample. You will then be asked to sit 
comfortably for another 5-minute period while heart rate, skin reactivity, and 
blood pressure are collected. During this time you will be asked to complete the 6 
anxiety questions one more time. 
 
You will be asked to come back to the PIRL for the exact same testing protocol 
approximately 1 week later.  
 
What are the risks and benefits of participating? 
 
There are no immediate direct benefits for participation in this study. However, we 
believe the information obtained will help us and others studying pain to better 
understand the various influences on the experience. 
 
The perceived risks of participation are minimal. The most evident risk is a momentary 
increase in pain and/or stiffness as a result of keeping your hand in the cold water for 1 
minute, but this should resolve after you start moving it once more. Additionally, as this 
is a pain provocation test, you will experience cold pain while your hand is submerged. 
The cold-water, while uncomfortable, is non-damaging in nature. There is little to 
minimal risk of frostbite and you are in complete control of all aspects of this test. You 
may remove your hand at any point if you choose. However, in the event that frostbite 
occurs, your hand will be immediately removed from the cold water, dried, and you will 
be taken to the closest Emergency Department (University Hospital) for medical 
management. Again, the risk of this is extremely minimal. Finally, you are likely to 
experience some increased heart rate, blood pressure, or sweating due to the cold-water 
immersion of your hand. Again, you are in complete control of the study and may remove 
your hand from the cold water at any point. Also, the researchers will be monitoring your 
heart rate during the study and if it should get too high (above 80% of your age-adjusted 
maximum) they will stop the study. It is possible that you will see a bit of bruising around 
the area of the pressure pain test. 
 
All data will be secured, but there is a chance of a privacy breach, in which case you will 
be immediately informed. 
 
In addition, there is a small chance that you may experience some irritation or a potential 
allergy to the gel used for the heart rate monitoring. If you are aware of any skin 
sensitivities to gel or adhesives, please let the researchers know ahead of time. If you do 
begin to experience itch or redness under any of the recording electrodes, the study will 
be stopped and medical management, if needed, will be offered. 
 
Finally, you will be asked to rate your own stress, anxiety and fear as part of this study. 
For some, providing personal information regarding your own anxieties and fears can be 
a difficult experience. Once again, you are in complete control and may choose to not 
provide this information. 
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Please note that medical treatment in the event of study related injury would be provided 
at no additional cost. 
 
Reminders and Responsibilities 
  
Participants will be required to refrain from eating, drinking sugary or caffeinated drinks, 
or engaging in vigorous physical activity (e.g., going to the gym) for the hour prior to 
each data collection period described above. In addition, please do not smoke or chew 
gum prior to your lab visit. 
   
How will participants’ information be kept confidential? 
 
All information will be kept confidential to the best of our ability. Your data will be 
stored separately from any information that could connect you to it. A unique 4-digit ID 
number will be generated for you and will be attached to your results in the study. The 
primary investigator at Western University, Dr. David Walton and PhD Student Michael 
Lukacs, will collect all of the data provided and analyze it as a de-identified group. All 
data will be stored on the secure, password protected and firewalled server of Western 
University. Identifying information will be retained for 7 years after study completion as 
per institutional policy. Western University’s REB will have access to participant’s data 
to ensure that it is following the proper laws and regulations. Outside of these 
acknowledged groups, your specific information (i.e., name) will not be shared with 
anyone without your express written consent to do so. Note: Only group averages will 
ever be published and you will not be identified. Data will be retained for a period of 7 
years before they are destroyed. You are free to request the removal of your data from the 
study up until this point.  
 
Will I be compensated for my participation? 
 
There is no direct financial compensation for participation in this study. However, those 
who incur costs beyond their usual daily routines (e.g., having to drive and park at Elborn 
College for this study) will have those costs reimbursed. 
 
What are the Rights of Participants? 
 
Participation in this study is completely voluntary. You may choose to not participate, 
withdraw from the study at any point in time without penalty and without any explanation 
required. If you choose not to participate or to leave the study at any time it will have no 
effect on your academic standing or your relationship with Western University or the 
researchers. Additionally, if you withdraw, you may request to have your data withdrawn 
from the study. Participation in this study does not prevent you from participating in any 
other research studies at the present time or future. If you are participating in another 
research study, we ask that you please inform of us of your participation. You do not 
waive any legal rights by signing the consent form.  
 
What if I want more information?  
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You may contact the lead researcher, Dr. David Walton at Western University (London, 
Canada) if you require any further clarification. His contact information can be found on 
the first page of this document. If you have any questions regarding your rights as a 
participant in this research study or the conduct of the study, you may contact the Office 
of the Research Ethics at (519) 661-3036 or by e-mail at ethics@uwo.ca.  
 
In addition, if you wish to receive a summarized copy of the results of this study, you 
may leave your email address on a separate sheet. This sheet will be held by the lead 
researcher, and the email address will only be used to provide the summarized results, 
after which the list will be destroyed.  
 
We thank you in advance for considering participation in this study. 
 




Dr. David Walton PT PhD     
Michael Lukacs PT, PhD Student       
Mohamad Fakhereddin, PhD Student 
Maryam Ghodrati, PhD Student  
Walter Siqueira, DDS, PhD   
Sandro Cestra, MPT Student        
Henry Tan, MPT Student 
Carmen Fung, MPT Student 
Harleen Nijjar, MPT Student 
Julian Quaglia, MPT Student 














If any part of this study causes you stress or anxiety that you find difficult to deal with, 
please feel free to contact us directly. The lead researcher is Dr. David Walton.  
 
You may also find the following resources helpful for dealing with stress:  
 
1. Supportive Family Member or Friend   
 
2. Your Family Doctor or Other Healthcare Provider 
 
3. Psychological Services (in your neighborhood hospital, university, or clinic) 
 
4. Telephone Support Lines (London and District Distress Centre; available 24 
hours/day) 
Distress Line      519-667-6711 
Crisis Response Line     519-433-2023 
5. Telehealth Ontario (available 24 hours/day)  
 
1-866-797-0000 
If your blood pressure should be abnormally high, or outside of normal range, you will 
receive a written note on the day of testing, and it will be suggested that you should 




Quantification of the stress response(s) and changes in conditioned pain modulation 
in reaction to the cold pressor task 
 
I have read the letter of information, have had the nature of the study explained to me and 
I agree to participate. All questions have been answered to my satisfaction.  
 
 
       
Participant name (print) 
 
 
             
Participant signature        Date 
 
 
             
Person obtaining consent (print)      Date 
 
 
       







Appendix D: VISION Pt. II Letter of Information and Consent 
Quantifying the normal stress response(s) and change in conditioned pain 
modulation following a novel virtual road collision simulation 




Dr. David Walton PT PhD 




Funding: Bone and Joint Institute Transdisciplinary Award 
 
Dear Sir/Madam,  
 
Thank you for your time in reviewing this letter of information and for considering 
participation in our study. Please be sure you’ve read this letter in its entirety and have 
had any questions answered to your satisfaction before consenting to participate. 
 
Invitation to Participate  
 
You are being invited to participate in a study examining how healthy people react to 
being exposed to a virtual reality car crash. You are being invited because you have 
indicated that you are otherwise healthy and have had no recent trauma or injury affecting 
your muscles, joints, bones or ligaments in the previous 3 months . Furthermore, you are 
at least 18 years of age and are able to read and understand conversational English.  
 
In order to be eligible to participate, you must not have any of the following conditions. 
Please tell the research coordinator if any of these apply to you.  
 
1. Significant health conditions including infection or a history of cardiovascular 
instability (e.g., heart disease, high or low blood pressure) 
2. Actively undergoing cancer treatment  
3. Any health condition that impairs your ability to feel touch, including stroke, 
multiple sclerosis, amyotrophic lateral sclerosis, or nerve pinch in your neck.  
4. An inability to have your cervical neck tested for dysfunction 
5. Neurological or systemic conditions that affect balance or postural control, and 
vestibular conditions that would affect ability to use virtual reality such as Vertigo 
or Benign paroxysmal positional vertigo (BPPV) (i.e. a disorder of the inner ear 
affecting balance) 
6. Have a history of migraines 
7. Visual pathology such as eye saccades (i.e. rapid eye movements) or other visual 
or movement-related disturbances 
8. Technophobia or fear of technology 




What the purpose of this study?  
 
Until now, it has been impossible to examine the range of stress responses for those 
involved in a car crash, especially at the time of the crash. We have successfully 
developed a new virtual reality-based road collision simulator that is designed to simulate 
the experience of being in a car crash without any of the biomechanical trauma. Thus, the 
purpose of this study is to examine how healthy people react to being part of a virtual car 
crash. We hope that the results of this study will help us better understand the 
connections between pain and stress. This study is conducted as part of the PhD work for 
PhD candidate Michael Lukacs. 
 
How long will you be in the study? 
 
This study will occur over two sessions separated by about one week, with the first one 
lasting just over an hour, and the second lasting only 20 minutes (roughly 2 hours total 
commitment). 
 
What are the study procedures? 
 
If you agree to participate, the study will be conducted in the Robot Biomechanics lab 
located in 030 1R16 in the Arts and Humanities Building, Western University in London, 
ON. Prior to your visit you are asked to avoid eating, drinking sugary or caffeinated 
drinks or participating in vigorous activity for the hour prior. As part of the screening 
process, your neck will be screened for dysfunction. You will be asked to rotate your 
head from side to side to ensure that you have full, pain-free range of motion of your 
cervical spine. You will then be asked to side-bend and rotate your head while a small 
amount of pressure is applied to the top of the head. Any production of symptoms would 
warrant exclusion from the study. On your visit, the following procedures will occur:  
 
5. You will be asked to complete a few questionnaires. These will start by asking 
things about you: your age, height, weight, sex at birth, time you awoke that day, 
and the quality of sleep you had the previous night. You will also be asked 6 short 
questions about your current level of anxiety. Finally, you will be asked a series 
of 9 questions regarding your fear of pain.  
 
6. Next, the researchers will place recording electrodes on your chest to measure 
your heart rate, and on two fingertips of your non-dominant hand to measure your 
skin’s reaction to stress. You will have the option of placing the electrodes 
yourself according to a diagram or having the researchers do it for you. Then you 
will be invited to sit comfortably for 5 minutes while the researchers record data 
coming from the different sensors. During these 5 minutes, you will be asked to 
refrain from using any electronic devices. At the end of the 5 minutes you will be 
asked to provide a small sample of saliva by placing a sterile cotton swab under 
your tongue for about 10 seconds before sealing it in a tube. It is important to note 
that none of the data we are collecting can be used for diagnostic purposes. 
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Finally, your sensitivity to pressure will be tested by one of the researchers who 
will apply pressure using a battery-powered device with a small rubber tip into 
your trapezius muscle with slowly increasing force until you indicate the 
sensation is painful. 
 
7. Next, you will be asked to sit in a car seat attached to a robot that is designed to 
mimic the movements of a car during driving. You will also be asked to wear a 
virtual reality helmet which will display the visuals of the simulation. In this 
simulation you will experience the role of being a passenger in a car. In addition, 
we will ask you to wear noise-cancelling headphones such that you are further 
immersed in the simulation. The movements of the robotic platform are 
synchronized with the visuals of the VR helmet in order to increase the 
immersiveness of the simulation.  For example, as you view the car turning a 
corner, the robot will also turn accordingly. In order to see how you tolerate being 
exposed to virtual reality, you will be exposed to a driving route with no crash for 
5 minutes in duration. You will be given 1 minute of rest. During this rest period, 
you will be asked to refrain from using electronic devices.  
 
8. You will again be asked to be exposed to a virtual driving route, but this time 
there will be a virtual car crash. During this crash, the platform you are sitting on 
will exert a small force against you to increase your immersion of feeling like you 
are in a car crash. The platform you are sitting on cannot accelerate beyond 1g, 
which is the equivalent of you sneezing. At any point you are free to quit the 
simulation should you choose. This route is only expected to take 1 minute in 
length.  
 
9. Immediately after the virtual car crash, the researchers will retest your pain 
sensitivity with the same rubber-tipped device. You will then be asked to sit 
comfortably for another 10-minute period while heart rate, and skin reactivity are 
continuously measured. At 5 minutes post, one more saliva sample will be 
collected using the same poly-cotton swabs. The researchers will re-evaluate your 
pain sensitivity every 3 minutes following. At the end of the 10 minutes, the 
researchers will ask you 6 questions to evaluate your anxiety, and 2 
questionnaires regarding both the immersiveness of the virtual simulation and the 
extent to which you experienced nausea or not. 
 
You are invited to come back for a second visit 3 to 7 days later to have your pain 
sensitivity, heart rate, and skin sensitivity re-evaluated under the same environmental 
conditions for evaluation of their test-retest reliability following the virtual car crash 
exposure. This is an optional study visit and your initial data will still be used even if you 
do not return. This second testing session does not include a virtual car crash and is 
expected to take 10-15 minutes. 
 




There are no immediate direct benefits for participation in this study. However, we 
believe the information obtained will help us and others studying pain to better 
understand the various influences of stress on the development of pain following 
injury/trauma. 
 
The perceived risks of participation are minimal. The most evident risk is a momentary 
increase the stiffness of the muscles of your neck, but this should resolve after you start 
moving it once more. You are also likely to experience some increased heart rate, blood 
pressure, or sweating due to stressful nature of the car crash simulation. Again, you are in 
complete control of the study and may quit the study at any time, should you choose to do 
so. Also, the researchers will be monitoring your heart rate during the study and if it 
should get too high (above 80% of your age-adjusted maximum) they will stop the study. 
It is also possible that you will see a bit of bruising around the area of the pressure pain 
test. Due to the nature of virtual reality, there is a very small risk that you may experience 
some nausea after experiencing the simulation. From previous work in our lab examining 
virtual reality and neck movement, nausea following exposure to virtual reality did not 
last longer than 24 hours. 
 
As we are examining the hypothesis that neck pain may be due to stress, it is possible that 
some people may experience pain and/or stiffness of the neck following exposure to the 
simulation. We expect these symptoms to be short-lived (i.e., not lasting more than 1-2 
days). We are confident that the magnitude of force that you will be exposed to in the 
simulator is not great enough to cause damage to the tissues of the neck. However, in the 
event that you should experience neck pain and/or stiffness that persist greater than 1-2 
days, we would ask you to follow up with your family physician for medical 
management. We will also send your family physician a letter outlining the nature of the 
study and the simulation that you were exposed to.  
 
All data will be secured, but there is a chance of a privacy breach, in which case you will 
be immediately informed. 
 
In addition, there is a small chance that you may experience some irritation or a potential 
allergy to the gel used for the heart rate monitoring. If you are aware of any skin 
sensitivities to gel or adhesives, please let the researchers know ahead of time. If you do 
begin to experience itch or redness under any of the recording electrodes, the study will 
be stopped and medical management, if needed, will be offered. 
 
Finally, you will be asked to rate your own stress, anxiety and fear as part of this study. 
For some, providing personal information regarding your own anxieties and fears can be 
a difficult experience. Once again, you are in complete control and may choose to not 
provide this information. 
 
Please note that medical treatment in the event of study related injury would be provided 
at no additional cost. 
 




Participants will be required to refrain from eating, drinking sugary or caffeinated drinks, 
or engaging in vigorous physical activity (e.g., going to the gym) for the hour prior to 
each data collection period described above. In addition, please do not smoke or chew 
gum prior to your lab visit. 
   
How will participants’ information be kept confidential? 
 
All information will be kept confidential to the best of our ability. Your data will be 
stored separately from any information that could connect you to it. A unique 4-digit ID 
number will be generated for you and will be attached to your results in the study. The 
primary investigator at Western University, Dr. David Walton and PhD Student Michael 
Lukacs, will collect all of the data provided and analyze it as a de-identified group. All 
data will be stored on the secure, password protected and firewalled server of Western 
University. Identifying information such as your full name, age, email address, sex and 
gender will be retained for 7 years after study completion as per institutional policy. 
Western University’s REB will have access to participant’s data to ensure that it is 
following the proper laws and regulations. Outside of these acknowledged groups, your 
specific information (i.e., name) will not be shared with anyone without your express 
written consent to do so. Note: Only group averages will ever be published and you will 
not be identified. Data will be retained for a period of 7 years before they are destroyed. 
You are free to request the removal of your data from the study up until this point.  
 
Will I be compensated for my participation? 
 
There is no direct financial compensation for participation in this study. However, those 
who incur costs beyond their usual daily routines (e.g., having to drive and park at 
Western University for this study) will have those costs reimbursed. 
 
What are the Rights of Participants? 
 
Participation in this study is completely voluntary. You may choose to not participate, 
withdraw from the study at any point in time without penalty and without any explanation 
required. If you choose not to participate or to leave the study at any time it will have no 
effect on your academic standing or your relationship with Western University or the 
researchers. Additionally, if you withdraw, you may request to have your data withdrawn 
from the study. Participation in this study does not prevent you from participating in any 
other research studies at the present time or future. If you are participating in another 
research study, we ask that you please inform of us of your participation. You do not 
waive any legal rights by signing the consent form.  
 
What if I want more information?  
 
You may contact the lead researcher, Dr. David Walton at Western University (London, 
Canada) if you require any further clarification. His contact information can be found on 
the first page of this document. If you have any questions regarding your rights as a 
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participant in this research study or the conduct of the study, you may contact the Office 
of the Research Ethics at (519) 661-3036 or by e-mail at ethics@uwo.ca.  
 
In addition, if you wish to receive a summarized copy of the results of this study, you 
may leave your email address on a separate sheet. This sheet will be held by the lead 
researcher, and the email address will only be used to provide the summarized results, 
after which the list will be destroyed.  
 
We thank you in advance for considering participation in this study. 
 




Dr. David Walton PT, PhD 
Dr. James Dickey PhD     
Michael Lukacs PT, PhD(c)   
      
        
  
If any part of this study causes you stress or anxiety that you find difficult to deal with, 
please feel free to contact us directly. The lead researcher is Dr. David Walton. In 
addition, if you do have neck pain, headache, and/or nausea persisting for more than 1-2 
days please do not hesitate to contact us. 
 
You may also find the following resources helpful for dealing with stress:  
 
10. Supportive Family Member or Friend   
 
11. Your Family Doctor or Other Healthcare Provider 
 
12. Psychological Services (in your neighborhood hospital, university, or clinic) 
 
13. Telephone Support Lines (London and District Distress Centre; available 24 
hours/day) 
Distress Line      519-667-6711 
Crisis Response Line     519-433-2023 








Quantification of the stress response(s) and changes in conditioned pain modulation 
in reaction to the cold pressor task 
 
I have read the letter of information, have had the nature of the study explained to me and 
I agree to participate. All questions have been answered to my satisfaction.  
 
 
       
Participant name (print) 
 
 
             
Participant signature        Date 
 
 
             
Person obtaining consent (print)      Date 
 
 
       











Appendix E: State-Trait Anxiety Inventory-6 (STAI-6) 
A number of statements which people have used to describe 
themselves are given below. Read each statement and then circle 
the most appropriate number to the right of the statement to 
indicate how you feel right now, at this moment. There are no right 
or wrong answers. Do not spend too much time on any one 
statement but give the answer which seems to describe your 
present feelings best. 
 
 
Not at all   Somewhat   Moderately  Very Much 
1. I feel calm………….   1       2                   3                   4 
2. I am tense………….                      1       2                   3                   4 
3. I feel upset…………   1       2                   3                   4 
4. I am relaxed……….   1       2                   3                   4 
5. I feel content……….   1       2                   3                   4 












Appendix F: Fear of Pain Questionnaire (FPQ-9) 
The items listed below describe painful experiences. Please look at each item and think 
about how FEARFUL you are of experiencing the PAIN associated with each item. If you 
have never experienced the PAIN of a particular item, please answer on the basis of how 
FEARFUL you expect you would be if you had such an experience. Circle one number for 
each item below to rate your FEAR OF PAIN in relation to each event. 
 
 Not at 
all 






1 2 3 4 5 
2.Having a foot 
doctor remove a 
wart from your 
foot with a sharp 
instrument 
 
1 2 3 4 5 
3.Getting a 
papercut on your 
finger 
1 2 3 4 5 
4.Receiving an 
injection in your 
mouth 
 
1 2 3 4 5 
5.Getting strong 
soap in both your 
eyes while bathing 
or showering 
 
1 2 3 4 5 
6.Having someone 
slam a heavy car 
door on your hand 
 
1 2 3 4 5 
7.Gulping a hot 
drink before it has 
cooled 
 
1 2 3 4 5 
8.Receiving an 
injection in your 
hip/buttocks 
 
1 2 3 4 5 
9.Falling down a 
flight of concrete 
stairs 




Appendix G:Presence Questionnaire  
Characterize your experience in the environment, by marking an "X" in the appropriate 
box of the 7-point scale, in accordance with the question content and descriptive labels. 
Please consider the entire scale when making your responses, as the intermediate levels 
may apply. Answer the questions independently in the order that they appear. Do not skip 
questions or return to a previous question to change your answer. 
WITH REGARD TO THE EXPERIENCED ENVIRONMENT 
1. How much were you able to control events? 
|________|________|________|________|________|________|________| 
 NOT AT ALL   SOMEWHAT   COMPLETELY  
2. How responsive was the environment to actions that you initiated (or performed)? 
|________|________|________|________|________|________|________|  
NOT     MODERATELY  COMPLETELY 
RESPONSIVE   RESPONSIVE   RESPONSIVE  
3. How natural did your interactions with the environment seem? 
|________|________|________|________|________|________|________|  
EXTREMELY   BORDERLINE   COMPLETELY  
ARTIFICAL        NATURAL  
4. How much did the visual aspects of the environment involve you? 
|________|________|________|________|________|________|________|  
NOT AT ALL   SOMEWHAT    COMPLETELY  
5. How natural was the mechanism which controlled movement through the 
environment?  
|________|________|________|________|________|________|________|  
EXTREMELY   BORDERLINE   COMPLETELY  
ARTIFICIAL        NATURAL  
6. How compelling was your sense of objects moving through space? 
|________|________|________|________|________|________|________|  
NOT AT ALL   MODERATELY           VERY  
COMPELLING       COMPELLING 
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 7. How much did your experiences in the virtual environment seem consistent with your 
real world experiences? 
 |________|________|________|________|________|________|________|  
NOT     MODERATELY            VERY  
CONSISTENT   CONSISTENT     CONSISTENT  
8. Were you able to anticipate what would happen next in response to the actions that you 
performed?  
|________|________|________|________|________|________|________|  
NOT AT ALL   SOMEWHAT   COMPLETELY  
9. How completely were you able to actively survey or search the environment using 
vision? |________|________|________|________|________|________|________|  
NOT AT ALL   SOMEWHAT   COMPLETELY  
10. How compelling was your sense of moving around inside the virtual environment? 
|________|________|________|________|________|________|________|  
NOT     MODERATELY           VERY  
COMPELLING   COMPELLING   COMPELLING  
11. How closely were you able to examine objects? 
|________|________|________|________|________|________|________|  
NOT AT ALL   PRETTY            VERY  
CLOSELY        CLOSELY  
12. How well could you examine objects from multiple viewpoints? 
|________|________|________|________|________|________|________|  
NOT AT ALL   SOMEWHAT   EXTENSIVELY 
13. How involved were you in the virtual environment experience? 
|________|________|________|________|________|________|________|  
NOT        MILDLY    COMPLETELY  




14. How much delay did you experience between your actions and expected outcomes? 
|________|________|________|________|________|________|________| 
NO DELAYS    MODERATE            LONG  
   DELAYS         DELAYS  
15. How quickly did you adjust to the virtual environment experience? 
|________|________|________|________|________|________|________|  
NOT AT ALL     SLOWLY       LESS THAN  
 ONE MINUTE  
16. How proficient in moving and interacting with the virtual environment did you feel at 
the end of the experience? 
 |________|________|________|________|________|________|________|  
NOT     REASONABLY            VERY  
PROFICIENT    PROFICIENT     PROFICIENT  
17. How much did the visual display quality interfere or distract you from performing 
assigned tasks or required activities? 
|________|________|________|________|________|________|________|  
NOT AT ALL   INTERFERED      PREVENTED  
SOMEWHAT       TASK PERFORMANCE  
18. How much did the control devices interfere with the performance of assigned tasks or 
with other activities? 
 |________|________|________|________|________|________|________| 
 NOT AT ALL   INTERFERED      INTERFERED  
SOMEWHAT        GREATLY  
19. How well could you concentrate on the assigned tasks or required activities rather 
than on the mechanisms used to perform those tasks or activities? 
|________|________|________|________|________|________|________|  




Appendix H: Simulator Sickness Questionnaire 
Instructions: Circle how much each symptom is affecting you right now. 
 
1. General Discomfort  None  Slight  Moderate Severe 
 
2. Fatigue     None  Slight  Moderate Severe 
 
3. Headache     None  Slight  Moderate Severe 
 
4. Eye Strain     None  Slight  Moderate Severe 
 
5. Difficulty Focusing   None  Slight  Moderate Severe 
 
6. Salivation Increasing   None  Slight  Moderate Severe 
 
7. Sweating     None  Slight  Moderate Severe 
 
8. Nausea     None  Slight  Moderate Severe 
 
9. Difficulty Concentrating   None  Slight  Moderate Severe 
 
10. Fullness of the Head  None  Slight  Moderate Severe 
 
11. Blurred Vision    None  Slight  Moderate Severe 
 
12. Dizziness With Eyes Open  None  Slight  Moderate Severe 
 
13. Dizziness With Eyes Closed  None  Slight  Moderate Severe 
 
14. Vertigo     None  Slight  Moderate Severe 
 
15. Stomach Awareness   None  Slight  Moderate Severe 
 
16. Burping     None  Slight  Moderate Severe 
 
 
*Vertigo is experienced as a loss of orientation with respect to vertical upright  
 
**Stomach awareness is usually used to indicate a feeling of discomfort which is just 
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